166237,1,Admission,O
166237,1,Date,O
166237,1,:,O
166237,1,[,O
166237,1,**2186-10-11**,O
166237,1,],O
166237,1,Discharge,O
166237,1,Date,O
166237,1,:,O
166237,1,[,O
166237,1,**2186-12-19**,O
166237,1,],O
166237,1,Service,O
166237,1,:,O
166237,1,MEDICINE,O
166237,1,Allergies,O
166237,1,:,O
166237,1,Wellbutrin,B-Drug
166237,1,/,O
166237,1,Kaopectate,B-Drug
166237,1,Attending,O
166237,1,:,O
166237,1,[,O
166237,1,**First,O
166237,1,Name3,O
166237,1,(,O
166237,1,LF,O
166237,1,),O
166237,1,4052**,O
166237,1,],O
166237,1,Chief,O
166237,1,Complaint,O
166237,1,:,O
166237,1,Non-responsiveness,O
166237,1,and,O
166237,1,hypotension,O
166237,1,Major,O
166237,1,Surgical,O
166237,1,or,O
166237,1,Invasive,O
166237,1,Procedure,O
166237,1,:,O
166237,1,T,O
166237,1,tube,O
166237,1,placement,O
166237,1,and,O
166237,1,cholangiogram,O
166237,1,EGD,O
166237,1,x,O
166237,1,4,O
166237,1,History,O
166237,1,of,O
166237,1,Present,O
166237,1,Illness,O
166237,1,:,O
166237,1,Patient,O
166237,1,is,O
166237,1,an,O
166237,1,84,O
166237,1,year,O
166237,1,old,O
166237,1,female,O
166237,1,with,O
166237,1,history,O
166237,1,of,O
166237,1,dementia,O
166237,1,",",O
166237,1,hypertension,O
166237,1,",",O
166237,1,type,O
166237,1,two,O
166237,1,diabetes,O
166237,1,mellitus,O
166237,1,",",O
166237,1,bipolar,O
166237,1,disease,O
166237,1,who,O
166237,1,presents,O
166237,1,with,O
166237,1,two,O
166237,1,weeks,O
166237,1,of,O
166237,1,declining,O
166237,1,social,O
166237,1,functioning,O
166237,1,and,O
166237,1,PO,O
166237,1,intake,O
166237,1,",",O
166237,1,usually,O
166237,1,able,O
166237,1,to,O
166237,1,walk,O
166237,1,with,O
166237,1,walker,O
166237,1,and,O
166237,1,perform,O
166237,1,ADL,O
166237,1,.,O
166237,1,CT,O
166237,1,scan,O
166237,1,at,O
166237,1,[,O
166237,1,**Hospital1,O
166237,1,2025**,O
166237,1,],O
166237,1,showed,O
166237,1,(,O
166237,1,-,O
166237,1,),O
166237,1,CT,O
166237,1,and,O
166237,1,(,O
166237,1,-,O
166237,1,),O
166237,1,troponins,O
166237,1,.,O
166237,1,Admitted,O
166237,1,to,O
166237,1,[,O
166237,1,**Hospital1,O
166237,1,18**,O
166237,1,],O
166237,1,[,O
166237,1,**10-12**,O
166237,1,],O
166237,1,",",O
166237,1,tox,O
166237,1,screen,O
166237,1,(,O
166237,1,-,O
166237,1,),O
166237,1,",",O
166237,1,CEs,O
166237,1,(,O
166237,1,-,O
166237,1,),O
166237,1,",",O
166237,1,primary,O
166237,1,team,O
166237,1,managing,O
166237,1,BP,B-Drug
166237,1,meds,I-Drug
166237,1,and,O
166237,1,psyche,B-Drug
166237,1,meds,I-Drug
166237,1,.,O
166237,1,Was,O
166237,1,being,O
166237,1,worked,O
166237,1,up,O
166237,1,on,O
166237,1,[,O
166237,1,**Wardname,O
166237,1,836**,O
166237,1,],O
166237,1,for,O
166237,1,renal,O
166237,1,failure,O
166237,1,and,O
166237,1,balancing,O
166237,1,HTN,B-Drug
166237,1,meds,I-Drug
166237,1,",",O
166237,1,when,O
166237,1,found,O
166237,1,by,O
166237,1,NSG,O
166237,1,staff,O
166237,1,to,O
166237,1,be,O
166237,1,'unresponsive,O
166237,1,',O
166237,1,with,O
166237,1,no,O
166237,1,breathing,O
166237,1,or,O
166237,1,radial,O
166237,1,pulse,O
166237,1,for,O
166237,1,20,O
166237,1,seconds,O
166237,1,.,O
166237,1,Code,O
166237,1,blue,O
166237,1,called,O
166237,1,",",O
166237,1,initial,O
166237,1,blood,O
166237,1,pressure,O
166237,1,80/50,O
166237,1,with,O
166237,1,improvement,O
166237,1,in,O
166237,1,mentation,O
166237,1,to,O
166237,1,baseline,O
166237,1,.,O
166237,1,Two,O
166237,1,hours,O
166237,1,after,O
166237,1,event,O
166237,1,",",O
166237,1,noted,O
166237,1,to,O
166237,1,have,O
166237,1,decreasing,O
166237,1,BPs,O
166237,1,to,O
166237,1,60s,O
166237,1,with,O
166237,1,concurrent,O
166237,1,mental,O
166237,1,status,O
166237,1,changes,O
166237,1,.,O
166237,1,Repeat,O
166237,1,BPs,O
166237,1,in,O
166237,1,trendelenburg,O
166237,1,resolved,O
166237,1,to,O
166237,1,110,O
166237,1,with,O
166237,1,return,O
166237,1,of,O
166237,1,mentation,O
166237,1,.,O
166237,1,She,O
166237,1,was,O
166237,1,transferred,O
166237,1,to,O
166237,1,the,O
166237,1,MICU,O
166237,1,on,O
166237,1,[,O
166237,1,**2186-10-15**,O
166237,1,],O
166237,1,for,O
166237,1,NSG,O
166237,1,concern,O
166237,1,of,O
166237,1,hypo,O
166237,1,tension,B-ADE
166237,1,.,O
166237,1,.,O
166237,1,In,O
166237,1,the,O
166237,1,MICU,O
166237,1,she,O
166237,1,had,O
166237,1,three,O
166237,1,more,O
166237,1,episodes,O
166237,1,.,O
166237,1,These,O
166237,1,were,O
166237,1,characterized,O
166237,1,by,O
166237,1,unresponsiveness,O
166237,1,",",O
166237,1,lack,O
166237,1,of,O
166237,1,a,O
166237,1,radial,O
166237,1,pulse,O
166237,1,(,O
166237,1,no,O
166237,1,femoral,O
166237,1,pulse,O
166237,1,was,O
166237,1,taken,O
166237,1,),O
166237,1,",",O
166237,1,and,O
166237,1,a,O
166237,1,post-ictal,O
166237,1,confusional,O
166237,1,state,O
166237,1,most,O
166237,1,consistent,O
166237,1,with,O
166237,1,seizures,O
166237,1,.,O
166237,1,Her,O
166237,1,EKG,O
166237,1,during,O
166237,1,these,O
166237,1,episodes,O
166237,1,was,O
166237,1,unremarkable,O
166237,1,",",O
166237,1,although,O
166237,1,she,O
166237,1,does,O
166237,1,have,O
166237,1,a,O
166237,1,baseline,O
166237,1,RBBB,O
166237,1,.,O
166237,2,Hence,O
166237,2,",",O
166237,2,heart,O
166237,2,block,O
166237,2,was,O
166237,2,deemed,O
166237,2,unlikely,O
166237,2,.,O
166237,2,MICU,O
166237,2,team,O
166237,2,was,O
166237,2,suspicious,O
166237,2,of,O
166237,2,seizure,O
166237,2,activity,O
166237,2,",",O
166237,2,given,O
166237,2,complete,O
166237,2,unresponsiveness,O
166237,2,to,O
166237,2,verbal,O
166237,2,and,O
166237,2,tactile,O
166237,2,stimuli,O
166237,2,",",O
166237,2,then,O
166237,2,confusion,O
166237,2,and,O
166237,2,return,O
166237,2,to,O
166237,2,baseline,O
166237,2,after,O
166237,2,episode,O
166237,2,.,O
166237,2,Further,O
166237,2,",",O
166237,2,given,O
166237,2,her,O
166237,2,diabetes,O
166237,2,and,O
166237,2,her,O
166237,2,labile,O
166237,2,blood,O
166237,2,pressure,O
166237,2,",",O
166237,2,autonomic,O
166237,2,seizures,O
166237,2,were,O
166237,2,of,O
166237,2,particular,O
166237,2,concern,O
166237,2,.,O
166237,2,She,O
166237,2,was,O
166237,2,worked,O
166237,2,up,O
166237,2,by,O
166237,2,multiple,O
166237,2,teams,O
166237,2,",",O
166237,2,including,O
166237,2,Neurology,O
166237,2,.,O
166237,2,Per,O
166237,2,neurology,O
166237,2,a,O
166237,2,head,O
166237,2,CT,O
166237,2,was,O
166237,2,obtained,O
166237,2,which,O
166237,2,indicated,O
166237,2,atrophy,O
166237,2,w/,O
166237,2,mild,O
166237,2,microangiopathic,O
166237,2,changes,O
166237,2,.,O
166237,2,She,O
166237,2,was,O
166237,2,put,O
166237,2,on,O
166237,2,EEG,O
166237,2,monitoring,O
166237,2,to,O
166237,2,capture,O
166237,2,seizure,O
166237,2,activity,O
166237,2,however,O
166237,2,she,O
166237,2,did,O
166237,2,not,O
166237,2,have,O
166237,2,an,O
166237,2,episode,O
166237,2,during,O
166237,2,monitoring,O
166237,2,.,O
166237,2,Other,O
166237,2,considerations,O
166237,2,were,O
166237,2,her,O
166237,2,baseline,O
166237,2,psyciatric,O
166237,2,disorder,O
166237,2,or,O
166237,2,medication,O
166237,2,regimen,O
166237,2,.,O
166237,2,She,O
166237,2,was,O
166237,2,seen,O
166237,2,by,O
166237,2,Psychiatry,O
166237,2,who,O
166237,2,do,O
166237,2,not,O
166237,2,feel,O
166237,2,her,O
166237,2,episodes,O
166237,2,of,O
166237,2,hypotension,O
166237,2,are,O
166237,2,entirely,O
166237,2,explained,O
166237,2,by,O
166237,2,her,O
166237,2,bipolar,O
166237,2,disorder,O
166237,2,.,O
166237,2,Finally,O
166237,2,nephrology,O
166237,2,was,O
166237,2,consulted,O
166237,2,to,O
166237,2,evaluate,O
166237,2,a,O
166237,2,renal,O
166237,2,source,O
166237,2,of,O
166237,2,her,O
166237,2,labile,O
166237,2,BP,O
166237,2,and,O
166237,2,possible,O
166237,2,source,O
166237,2,of,O
166237,2,hypotensive,B-ADE
166237,2,episodes,I-ADE
166237,2,.,O
166237,2,Nephrology,O
166237,2,determined,O
166237,2,she,O
166237,2,did,O
166237,2,not,O
166237,2,have,O
166237,2,RAS,O
166237,2,by,O
166237,2,US,O
166237,2,and,O
166237,2,Captopril,B-Drug
166237,2,study,O
166237,2,and,O
166237,2,did,O
166237,2,not,O
166237,2,feel,O
166237,2,that,O
166237,2,her,O
166237,2,labile,O
166237,2,BP,O
166237,2,was,O
166237,2,renal,O
166237,2,in,O
166237,2,origin,O
166237,2,.,O
166237,2,Ultimately,O
166237,2,",",O
166237,2,it,O
166237,2,was,O
166237,2,felt,O
166237,2,that,O
166237,2,a,O
166237,2,polypharmacy,O
166237,2,of,O
166237,2,her,O
166237,2,BP,B-Drug
166237,2,and,I-Drug
166237,2,anti-psychotic,I-Drug
166237,2,medications,I-Drug
166237,2,were,O
166237,2,responsible,O
166237,2,for,O
166237,2,these,O
166237,2,episodes,O
166237,2,.,O
166237,2,Her,O
166237,2,BP/,B-Drug
166237,2,Psych,I-Drug
166237,2,med,I-Drug
166237,2,regimen,O
166237,2,were,O
166237,2,tapered,O
166237,2,and,O
166237,2,she,O
166237,2,has,O
166237,2,been,O
166237,2,stable,O
166237,2,for,O
166237,2,3,O
166237,2,days,O
166237,2,.,O
166237,2,She,O
166237,2,was,O
166237,2,transferred,O
166237,2,to,O
166237,2,[,O
166237,2,**Wardname,O
166237,2,**,O
166237,2,],O
166237,2,[,O
166237,2,**2186-10-17**,O
166237,2,],O
166237,2,for,O
166237,2,further,O
166237,2,workup,O
166237,2,of,O
166237,2,an,O
166237,2,anion,O
166237,2,gap,O
166237,2,and,O
166237,2,elevated,O
166237,2,WBC,O
166237,2,prior,O
166237,2,to,O
166237,2,anticipated,O
166237,2,discharge,O
166237,2,to,O
166237,2,a,O
166237,2,rehab,O
166237,2,facility,O
166237,2,.,O
166237,2,.,O
166237,2,Of,O
166237,2,note,O
166237,2,",",O
166237,2,recently,O
166237,2,hospitalized,O
166237,2,@,O
166237,2,QuincyMC,O
166237,2,for,O
166237,2,mania,O
166237,2,",",O
166237,2,had,O
166237,2,episode,O
166237,2,of,O
166237,2,syncope,O
166237,2,;,O
166237,2,workup,O
166237,2,head,O
166237,2,CT,O
166237,2,",",O
166237,2,head,O
166237,2,MRI,O
166237,2,",",O
166237,2,neck,O
166237,2,MRA,O
166237,2,",",O
166237,2,carotid,O
166237,2,doppler,O
166237,2,studies,O
166237,2,",",O
166237,2,EEG,O
166237,2,",",O
166237,2,CXR,O
166237,2,",",O
166237,2,and,O
166237,2,echocardiogram,O
166237,2,.,O
166237,2,Head,O
166237,2,MRI,O
166237,2,notable,O
166237,2,for,O
166237,2,periventricular,O
166237,2,white,O
166237,2,matter,O
166237,2,changes,O
166237,2,suggesting,O
166237,2,small,O
166237,2,vessel,O
166237,2,disease,O
166237,2,.,O
166237,2,TTE,O
166237,2,showed,O
166237,2,normal,O
166237,2,sized,O
166237,2,LV,O
166237,2,with,O
166237,2,hyperdynamic,O
166237,2,systolic,O
166237,2,function,O
166237,3,and,O
166237,3,EF,O
166237,3,of,O
166237,3,75,O
166237,3,%,O
166237,3,.,O
166237,3,EEG,O
166237,3,normal,O
166237,3,.,O
166237,3,MRA,O
166237,3,of,O
166237,3,neck,O
166237,3,showed,O
166237,3,65-70,O
166237,3,%,O
166237,3,stenosis,O
166237,3,of,O
166237,3,internal,O
166237,3,carotids,O
166237,3,bilaterally,O
166237,3,.,O
166237,3,Past,O
166237,3,Medical,O
166237,3,History,O
166237,3,:,O
166237,3,1,O
166237,3,.,O
166237,3,Bipolar,O
166237,3,d/o,O
166237,3,(,O
166237,3,recent,O
166237,3,hospitalization,O
166237,3,at,O
166237,3,[,O
166237,3,**Hospital1,O
166237,3,392**,O
166237,3,],O
166237,3,for,O
166237,3,manic,O
166237,3,episode,O
166237,3,:,O
166237,3,[,O
166237,3,**Date,O
166237,3,range,O
166237,3,(,O
166237,3,1,O
166237,3,),O
166237,3,39296**,O
166237,3,],O
166237,3,;,O
166237,3,peridiocally,O
166237,3,on,O
166237,3,medical,O
166237,3,floor,O
166237,3,for,O
166237,3,syncope,O
166237,3,eval,O
166237,3,),O
166237,3,2,O
166237,3,.,O
166237,3,Mild,O
166237,3,dementia,O
166237,3,3,O
166237,3,.,O
166237,3,Refractory,O
166237,3,HTN,O
166237,3,4,O
166237,3,.,O
166237,3,DM,O
166237,3,type,O
166237,3,II,O
166237,3,5,O
166237,3,.,O
166237,3,Hypothyroidism,O
166237,3,6,O
166237,3,.,O
166237,3,Chronic,O
166237,3,Kidney,O
166237,3,Disease,O
166237,3,7,O
166237,3,.,O
166237,3,Bilateral,O
166237,3,hearing,O
166237,3,loss,O
166237,3,8,O
166237,3,.,O
166237,3,Arthritis,O
166237,3,9,O
166237,3,.,O
166237,3,Bilateral,O
166237,3,carotid,O
166237,3,stenosis,O
166237,3,Social,O
166237,3,History,O
166237,3,:,O
166237,3,Lives,O
166237,3,at,O
166237,3,[,O
166237,3,**Doctor,O
166237,3,Last,O
166237,3,Name,O
166237,3,**,O
166237,3,],O
166237,3,house,O
166237,3,",",O
166237,3,Has,O
166237,3,4,O
166237,3,kids,O
166237,3,all,O
166237,3,living,O
166237,3,locally,O
166237,3,",",O
166237,3,widowed,O
166237,3,.,O
166237,3,Distant,O
166237,3,smoking,O
166237,3,history,O
166237,3,",",O
166237,3,distant,O
166237,3,social,O
166237,3,EtOH,O
166237,3,.,O
166237,3,Family,O
166237,3,History,O
166237,3,:,O
166237,3,Mother,O
166237,3,had,O
166237,3,psychiatric,O
166237,3,disease,O
166237,3,with,O
166237,3,multiple,O
166237,3,psychiatric,O
166237,3,admissions,O
166237,3,",",O
166237,3,died,O
166237,3,in,O
166237,3,a,O
166237,3,state,O
166237,3,hospital,O
166237,3,.,O
166237,3,Physical,O
166237,3,Exam,O
166237,3,:,O
166237,3,ON,O
166237,3,ADMISSION,O
166237,3,:,O
166237,3,Vitals,O
166237,3,-,O
166237,3,T,O
166237,3,97.6,O
166237,3,",",O
166237,3,BP,O
166237,3,175/57,O
166237,3,",",O
166237,3,HR,O
166237,3,69,O
166237,3,",",O
166237,3,RR,O
166237,3,20,O
166237,3,",",O
166237,3,O2,O
166237,3,sat,O
166237,3,96,O
166237,3,%,O
166237,3,3L,O
166237,3,NC,O
166237,3,General,O
166237,3,-,O
166237,3,elderly,O
166237,3,female,O
166237,3,",",O
166237,3,pleasant,O
166237,3,",",O
166237,3,NAD,O
166237,3,HEENT,O
166237,3,-,O
166237,3,PERRL,O
166237,3,",",O
166237,3,OP,O
166237,3,clr,O
166237,3,",",O
166237,3,MMM,O
166237,3,",",O
166237,3,JVP,O
166237,3,flat,O
166237,3,CV,O
166237,3,-,O
166237,3,RRR,O
166237,3,",",O
166237,3,[,O
166237,3,**1-17**,O
166237,3,],O
166237,3,syst,O
166237,3,mur,O
166237,3,at,O
166237,3,apex,O
166237,3,Chest,O
166237,3,-,O
166237,3,coarse,O
166237,3,R,O
166237,3,basilar,O
166237,3,crackles,O
166237,3,Abdomen,O
166237,3,-,O
166237,3,NABS,O
166237,3,",",O
166237,3,soft,O
166237,3,",",O
166237,3,NT/ND,O
166237,3,",",O
166237,3,no,O
166237,3,g/r,O
166237,3,;,O
166237,3,soft,O
166237,3,abdominal,O
166237,3,bruit,O
166237,3,Ext,O
166237,3,-,O
166237,3,trace,O
166237,3,bilat,O
166237,3,edema,O
166237,3,.,O
166237,3,ON,O
166237,3,TRANSFER,O
166237,3,to,O
166237,3,[,O
166237,3,**Hospital,O
166237,3,Ward,O
166237,3,Name,O
166237,3,**,O
166237,3,],O
166237,3,7,O
166237,3,:,O
166237,3,Physical,O
166237,3,Examination,O
166237,3,Vitals,O
166237,3,-,O
166237,3,T,O
166237,3,96.9,O
166237,3,",",O
166237,3,BP,O
166237,3,160/60,O
166237,3,",",O
166237,3,HR,O
166237,3,68,O
166237,3,",",O
166237,3,RR,O
166237,3,20,O
166237,3,",",O
166237,3,O2,O
166237,3,sat,O
166237,3,99,O
166237,3,%,O
166237,3,RA,O
166237,3,General,O
166237,3,-,O
166237,3,elderly,O
166237,3,female,O
166237,3,",",O
166237,3,pleasant,O
166237,3,",",O
166237,3,NAD,O
166237,3,HEENT,O
166237,3,-,O
166237,3,PERRL,O
166237,3,",",O
166237,3,sclera,O
166237,3,are,O
166237,3,erythematous,O
166237,3,",",O
166237,3,OP,O
166237,3,clr,O
166237,3,",",O
166237,3,MMM,O
166237,3,",",O
166237,3,JVP,O
166237,3,flat,O
166237,3,CV,O
166237,3,-,O
166237,3,RRR,O
166237,3,",",O
166237,3,[,O
166237,3,**1-17**,O
166237,3,],O
166237,3,syst,O
166237,3,mur,O
166237,3,at,O
166237,3,apex,O
166237,3,Chest,O
166237,3,-,O
166237,3,clear,O
166237,3,to,O
166237,3,ascultation,O
166237,3,bilaterally,O
166237,3,Abdomen,O
166237,3,-,O
166237,3,NABS,O
166237,3,",",O
166237,3,soft,O
166237,3,",",O
166237,4,NT/ND,O
166237,4,",",O
166237,4,no,O
166237,4,g/r,O
166237,4,;,O
166237,4,soft,O
166237,4,abdominal,O
166237,4,bruit,O
166237,4,Ext,O
166237,4,-,O
166237,4,bilat,O
166237,4,edema,O
166237,4,4+,O
166237,4,on,O
166237,4,hands,O
166237,4,",",O
166237,4,2+,O
166237,4,on,O
166237,4,LE,O
166237,4,",",O
166237,4,WWP,O
166237,4,Neuro,O
166237,4,-,O
166237,4,AOx3,O
166237,4,",",O
166237,4,[,O
166237,4,**3-17**,O
166237,4,],O
166237,4,bl,O
166237,4,UE,O
166237,4,and,O
166237,4,LE,O
166237,4,strenght,O
166237,4,bl,O
166237,4,.,O
166237,4,sensation,O
166237,4,intact,O
166237,4,throughout,O
166237,4,symmetrically,O
166237,4,.,O
166237,4,Pertinent,O
166237,4,Results,O
166237,4,:,O
166237,4,LABS,O
166237,4,ON,O
166237,4,ADMISSION,O
166237,4,[,O
166237,4,**2186-10-11**,O
166237,4,],O
166237,4,:,O
166237,4,[,O
166237,4,**2186-10-11**,O
166237,4,],O
166237,4,04:45PM,O
166237,4,URINE,O
166237,4,COLOR-Yellow,O
166237,4,APPEAR-Clear,O
166237,4,SP,O
166237,4,[,O
166237,4,**Last,O
166237,4,Name,O
166237,4,(,O
166237,4,un,O
166237,4,),O
166237,4,155**,O
166237,4,],O
166237,4,-1.016,O
166237,4,[,O
166237,4,**2186-10-11**,O
166237,4,],O
166237,4,04:45PM,O
166237,4,URINE,O
166237,4,BLOOD-LG,O
166237,4,NITRITE-NEG,O
166237,4,PROTEIN-30,O
166237,4,GLUCOSE-250,O
166237,4,KETONE-15,O
166237,4,BILIRUBIN-NEG,O
166237,4,UROBILNGN-NEG,O
166237,4,PH-6.5,O
166237,4,LEUK-NEG,O
166237,4,[,O
166237,4,**2186-10-11**,O
166237,4,],O
166237,4,04:45PM,O
166237,4,URINE,O
166237,4,RBC-,O
166237,4,>,O
166237,4,50,O
166237,4,WBC-0-2,O
166237,4,BACTERIA-FEW,O
166237,4,YEAST-NONE,O
166237,4,EPI-0-2,O
166237,4,[,O
166237,4,**2186-10-11**,O
166237,4,],O
166237,4,04:45PM,O
166237,4,URINE,O
166237,4,HYALINE-0-2,O
166237,4,[,O
166237,4,**2186-10-11**,O
166237,4,],O
166237,4,12:55PM,O
166237,4,GLUCOSE-209*,O
166237,4,UREA,O
166237,4,N-36*,O
166237,4,CREAT-1.6*,O
166237,4,SODIUM-144,O
166237,4,POTASSIUM-3.5,O
166237,4,CHLORIDE-104,O
166237,4,TOTAL,O
166237,4,CO2-28,O
166237,4,ANION,O
166237,4,GAP-16,O
166237,4,[,O
166237,4,**2186-10-11**,O
166237,4,],O
166237,4,12:55PM,O
166237,4,ALT,O
166237,4,(,O
166237,4,SGPT,O
166237,4,),O
166237,4,-16,O
166237,4,AST,O
166237,4,(,O
166237,4,SGOT,O
166237,4,),O
166237,4,-23,O
166237,4,LD,O
166237,4,(,O
166237,4,LDH,O
166237,4,),O
166237,4,-196,O
166237,4,ALK,O
166237,4,PHOS-67,O
166237,4,TOT,O
166237,4,BILI-0.5,O
166237,4,[,O
166237,4,**2186-10-11**,O
166237,4,],O
166237,4,12:55PM,O
166237,4,ALBUMIN-3.6,O
166237,4,CALCIUM-8.4,O
166237,4,PHOSPHATE-3.7,O
166237,4,MAGNESIUM-2.5,O
166237,4,IRON-40,O
166237,4,[,O
166237,4,**2186-10-11**,O
166237,4,],O
166237,4,12:55PM,O
166237,4,calTIBC-263,O
166237,4,VIT,O
166237,4,B12-609,O
166237,4,FOLATE-16.5,O
166237,4,FERRITIN-102,O
166237,4,TRF-202,O
166237,4,[,O
166237,4,**2186-10-11**,O
166237,4,],O
166237,4,12:55PM,O
166237,4,TSH-0.089*,O
166237,4,[,O
166237,4,**2186-10-11**,O
166237,4,],O
166237,4,12:55PM,O
166237,4,CRP-9.1*,O
166237,4,[,O
166237,4,**2186-10-11**,O
166237,4,],O
166237,4,12:55PM,O
166237,4,WBC-9.4,O
166237,4,RBC-3.66*,O
166237,4,HGB-11.4*,O
166237,4,HCT-34.1*,O
166237,4,MCV-93,O
166237,4,MCH-31.1,O
166237,4,MCHC-33.3,O
166237,4,RDW-13.9,O
166237,4,[,O
166237,4,**2186-10-11**,O
166237,4,],O
166237,4,12:55PM,O
166237,4,PLT,O
166237,4,COUNT-273,O
166237,4,[,O
166237,4,**2186-10-11**,O
166237,4,],O
166237,4,12:55PM,O
166237,4,PT-11.3,O
166237,4,INR,O
166237,4,(,O
166237,4,PT,O
166237,4,),O
166237,4,-1.0,O
166237,4,[,O
166237,4,**2186-10-11**,O
166237,4,],O
166237,4,12:55PM,O
166237,4,SED,O
166237,4,RATE-46*,O
166237,4,[,O
166237,4,**2186-10-11**,O
166237,4,],O
166237,4,12:10AM,O
166237,4,GLUCOSE-170*,O
166237,4,UREA,O
166237,4,N-41*,O
166237,4,CREAT-1.7*,O
166237,4,SODIUM-145,O
166237,4,POTASSIUM-3.4,O
166237,4,CHLORIDE-105,O
166237,4,TOTAL,O
166237,4,CO2-27,O
166237,4,ANION,O
166237,4,GAP-16,O
166237,4,[,O
166237,4,**2186-10-11**,O
166237,4,],O
166237,4,12:10AM,O
166237,4,estGFR-Using,O
166237,4,this,O
166237,4,[,O
166237,4,**2186-10-11**,O
166237,4,],O
166237,4,12:10AM,O
166237,4,CK,O
166237,4,(,O
166237,4,CPK,O
166237,4,),O
166237,4,-314*,O
166237,4,[,O
166237,4,**2186-10-11**,O
166237,4,],O
166237,4,12:10AM,O
166237,4,CK-MB-3,O
166237,4,cTropnT-0.02*,O
166237,4,[,O
166237,4,**2186-10-11**,O
166237,4,],O
166237,4,12:10AM,O
166237,4,ASA-NEG,O
166237,4,ETHANOL-NEG,O
166237,4,ACETMNPHN-NEG,O
166237,4,bnzodzpn-NEG,O
166237,4,barbitrt-NEG,O
166237,4,tricyclic-NEG,O
166237,4,[,O
166237,4,**2186-10-11**,O
166237,4,],O
166237,4,12:10AM,O
166237,4,WBC-10.9,O
166237,4,RBC-3.61*,O
166237,4,HGB-11.4*,O
166237,4,HCT-33.6*,O
166237,4,MCV-93,O
166237,4,MCH-31.6,O
166237,4,MCHC-33.9,O
166237,4,RDW-13.6,O
166237,4,[,O
166237,4,**2186-10-11**,O
166237,4,],O
166237,4,12:10AM,O
166237,4,NEUTS-80.1*,O
166237,4,LYMPHS-14.7*,O
166237,4,MONOS-3.4,O
166237,4,EOS-0.8,O
166237,4,BASOS-0.9,O
166237,4,[,O
166237,4,**2186-10-11**,O
166237,4,],O
166237,4,12:10AM,O
166237,4,PLT,O
166237,4,COUNT-298,O
166237,4,.,O
166237,4,.,O
166237,4,Laboratory,O
166237,4,Studies,O
166237,4,(,O
166237,4,on,O
166237,4,transfer,O
166237,4,to,O
166237,4,[,O
166237,4,**Wardname,O
166237,4,**,O
166237,4,],O
166237,4,),O
166237,4,:,O
166237,4,ABG,O
166237,4,:,O
166237,4,94,O
166237,4,",",O
166237,4,28,O
166237,4,",",O
166237,4,7.42,O
166237,4,",",O
166237,4,19,O
166237,4,",",O
166237,4,base,O
166237,4,-4,O
166237,4,CBC,O
166237,5,:,O
166237,5,17.4,O
166237,5,",",O
166237,5,38.8,O
166237,5,",",O
166237,5,315,O
166237,5,Chem7,O
166237,5,:,O
166237,5,139,O
166237,5,",",O
166237,5,3.8,O
166237,5,",",O
166237,5,102,O
166237,5,",",O
166237,5,19,O
166237,5,",",O
166237,5,43,O
166237,5,",",O
166237,5,1.2,O
166237,5,",",O
166237,5,243,O
166237,5,CK,O
166237,5,18,O
166237,5,",",O
166237,5,Ca,O
166237,5,8.9,O
166237,5,",",O
166237,5,Mg,O
166237,5,2.4,O
166237,5,",",O
166237,5,P,O
166237,5,3.4,O
166237,5,PT,O
166237,5,11.5,O
166237,5,",",O
166237,5,PTT,O
166237,5,26.3,O
166237,5,",",O
166237,5,INR,O
166237,5,1.0,O
166237,5,UA,O
166237,5,:,O
166237,5,straw,O
166237,5,",",O
166237,5,clear,O
166237,5,",",O
166237,5,1.017,O
166237,5,",",O
166237,5,5.0,O
166237,5,",",O
166237,5,bld,O
166237,5,large,O
166237,5,",",O
166237,5,prot,O
166237,5,30,O
166237,5,",",O
166237,5,gluc,O
166237,5,1000,O
166237,5,",",O
166237,5,ket,O
166237,5,50,O
166237,5,",",O
166237,5,RBC,O
166237,5,84,O
166237,5,",",O
166237,5,WBC,O
166237,5,0,O
166237,5,",",O
166237,5,Bact,O
166237,5,none,O
166237,5,",",O
166237,5,Yest,O
166237,5,none,O
166237,5,",",O
166237,5,epi,O
166237,5,<,O
166237,5,1,O
166237,5,",",O
166237,5,(,O
166237,5,negative,O
166237,5,for,O
166237,5,Urobbil,O
166237,5,",",O
166237,5,Bili,O
166237,5,",",O
166237,5,Leuk,O
166237,5,",",O
166237,5,Nitr,O
166237,5,),O
166237,5,Urine,O
166237,5,Cre,O
166237,5,77,O
166237,5,",",O
166237,5,Prot,O
166237,5,51,O
166237,5,",",O
166237,5,Prot/Cre,O
166237,5,0.7,O
166237,5,.,O
166237,5,Radiographic,O
166237,5,Studies,O
166237,5,:,O
166237,5,Chest,O
166237,5,AP,O
166237,5,(,O
166237,5,prelim,O
166237,5,),O
166237,5,-,O
166237,5,Allowing,O
166237,5,for,O
166237,5,difference,O
166237,5,in,O
166237,5,technique,O
166237,5,",",O
166237,5,cardiomediastinal,O
166237,5,silhouette,O
166237,5,is,O
166237,5,unchanged,O
166237,5,with,O
166237,5,mild,O
166237,5,cardiomegaly,O
166237,5,.,O
166237,5,There,O
166237,5,is,O
166237,5,no,O
166237,5,pneumothorax,O
166237,5,or,O
166237,5,pleural,O
166237,5,effusion,O
166237,5,.,O
166237,5,The,O
166237,5,lungs,O
166237,5,are,O
166237,5,clear,O
166237,5,.,O
166237,5,.,O
166237,5,(,O
166237,5,[,O
166237,5,**2186-10-13**,O
166237,5,],O
166237,5,),O
166237,5,ECG,O
166237,5,:,O
166237,5,NSR,O
166237,5,",",O
166237,5,RBBB,O
166237,5,",",O
166237,5,LAFB,O
166237,5,",",O
166237,5,LVH,O
166237,5,.,O
166237,5,unchanged,O
166237,5,from,O
166237,5,prior,O
166237,5,.,O
166237,5,(,O
166237,5,[,O
166237,5,**2186-10-16**,O
166237,5,],O
166237,5,),O
166237,5,EEG,O
166237,5,IMPRESSION,O
166237,5,:,O
166237,5,This,O
166237,5,telemetry,O
166237,5,captured,O
166237,5,no,O
166237,5,pushbutton,O
166237,5,activations,O
166237,5,for,O
166237,5,symptoms,O
166237,5,.,O
166237,5,Routine,O
166237,5,sampling,O
166237,5,and,O
166237,5,automated,O
166237,5,detection,O
166237,5,programs,O
166237,5,recorded,O
166237,5,no,O
166237,5,epileptiform,O
166237,5,features,O
166237,5,or,O
166237,5,electrographic,O
166237,5,seizures,O
166237,5,.,O
166237,5,There,O
166237,5,was,O
166237,5,some,O
166237,5,multifocal,O
166237,5,slowing,O
166237,5,admixed,O
166237,5,to,O
166237,5,the,O
166237,5,waking,O
166237,5,background,O
166237,5,",",O
166237,5,but,O
166237,5,this,O
166237,5,would,O
166237,5,be,O
166237,5,assessed,O
166237,5,better,O
166237,5,through,O
166237,5,routine,O
166237,5,EEG,O
166237,5,tracings,O
166237,5,.,O
166237,5,There,O
166237,5,were,O
166237,5,no,O
166237,5,areas,O
166237,5,of,O
166237,5,fixed,O
166237,5,focal,O
166237,5,slowing,O
166237,5,",",O
166237,5,and,O
166237,5,there,O
166237,5,were,O
166237,5,no,O
166237,5,epileptiform,O
166237,5,features,O
166237,5,.,O
166237,5,.,O
166237,5,(,O
166237,5,[,O
166237,5,**2186-10-14**,O
166237,5,],O
166237,5,),O
166237,5,EEG,O
166237,5,IMPRESSION,O
166237,5,:,O
166237,5,This,O
166237,5,is,O
166237,5,an,O
166237,5,abnormal,O
166237,5,portable,O
166237,5,EEG,O
166237,5,in,O
166237,5,the,O
166237,5,waking,O
166237,5,and,O
166237,5,drowsy,O
166237,5,states,O
166237,5,due,O
166237,5,to,O
166237,5,intermittent,O
166237,5,brief,O
166237,5,bursts,O
166237,5,of,O
166237,5,mixed,O
166237,5,frequency,O
166237,5,slowing,O
166237,5,seen,O
166237,5,in,O
166237,5,the,O
166237,5,temporal,O
166237,5,regions,O
166237,5,bilaterally,O
166237,5,",",O
166237,5,independently,O
166237,5,and,O
166237,5,asynchronously,O
166237,5,.,O
166237,5,The,O
166237,5,findings,O
166237,5,suggest,O
166237,5,underlying,O
166237,5,subcortical,O
166237,5,dysfunction,O
166237,5,in,O
166237,5,those,O
166237,5,regions,O
166237,5,.,O
166237,5,In,O
166237,5,a,O
166237,5,patient,O
166237,5,of,O
166237,5,this,O
166237,5,age,O
166237,5,",",O
166237,5,vascular,O
166237,5,disease,O
166237,5,would,O
166237,5,be,O
166237,5,among,O
166237,5,the,O
166237,5,common,O
166237,5,causes,O
166237,5,.,O
166237,5,In,O
166237,5,addition,O
166237,5,",",O
166237,5,there,O
166237,5,were,O
166237,5,brief,O
166237,5,bursts,O
166237,5,of,O
166237,5,generalized,O
166237,6,mixed,O
166237,6,frequency,O
166237,6,slowing,O
166237,6,",",O
166237,6,more,O
166237,6,non-specific,O
166237,6,in,O
166237,6,etiology,O
166237,6,.,O
166237,6,There,O
166237,6,were,O
166237,6,no,O
166237,6,clearly,O
166237,6,epileptiform,O
166237,6,features,O
166237,6,.,O
166237,6,No,O
166237,6,electrographic,O
166237,6,seizures,O
166237,6,were,O
166237,6,noted,O
166237,6,.,O
166237,6,.,O
166237,6,(,O
166237,6,[,O
166237,6,**2186-10-13**,O
166237,6,],O
166237,6,),O
166237,6,CT,O
166237,6,HEAD,O
166237,6,IMPRESSION,O
166237,6,:,O
166237,6,Moderate,O
166237,6,degree,O
166237,6,of,O
166237,6,atrophy,O
166237,6,with,O
166237,6,mild,O
166237,6,microangiopathic,O
166237,6,changes,O
166237,6,.,O
166237,6,.,O
166237,6,(,O
166237,6,[,O
166237,6,**2186-10-13**,O
166237,6,],O
166237,6,),O
166237,6,RENAL,O
166237,6,US,O
166237,6,IMPRESSION,O
166237,6,:,O
166237,6,Study,O
166237,6,limited,O
166237,6,by,O
166237,6,patient,O
166237,6,factors,O
166237,6,:,O
166237,6,blood,O
166237,6,flow,O
166237,6,to,O
166237,6,both,O
166237,6,kidneys,O
166237,6,",",O
166237,6,there,O
166237,6,is,O
166237,6,no,O
166237,6,hydronephrosis,O
166237,6,",",O
166237,6,nephrolithiasis,O
166237,6,",",O
166237,6,simple,O
166237,6,cysts,O
166237,6,in,O
166237,6,both,O
166237,6,kidneys,O
166237,6,.,O
166237,6,(,O
166237,6,[,O
166237,6,**2186-10-16**,O
166237,6,],O
166237,6,),O
166237,6,RENAL,O
166237,6,CAPTOPRIL,B-Drug
166237,6,SCAN,O
166237,6,IMPRESSION,O
166237,6,:,O
166237,6,Essentially,O
166237,6,normal,O
166237,6,captopril,B-Drug
166237,6,renal,O
166237,6,scan,O
166237,6,.,O
166237,6,Specifically,O
166237,6,",",O
166237,6,no,O
166237,6,evidence,O
166237,6,of,O
166237,6,renal,O
166237,6,artery,O
166237,6,stenosis,O
166237,6,.,O
166237,6,.,O
166237,6,(,O
166237,6,[,O
166237,6,**10-17**,O
166237,6,],O
166237,6,and,O
166237,6,[,O
166237,6,**2186-10-17**,O
166237,6,],O
166237,6,),O
166237,6,EEG,O
166237,6,:,O
166237,6,IMPRESSION,O
166237,6,:,O
166237,6,This,O
166237,6,telemetry,O
166237,6,captured,O
166237,6,no,O
166237,6,pushbutton,O
166237,6,activations,O
166237,6,for,O
166237,6,symptoms,O
166237,6,.,O
166237,6,Routine,O
166237,6,sampling,O
166237,6,and,O
166237,6,automated,O
166237,6,detection,O
166237,6,programs,O
166237,6,recorded,O
166237,6,no,O
166237,6,epileptiform,O
166237,6,features,O
166237,6,or,O
166237,6,electrographic,O
166237,6,seizures,O
166237,6,.,O
166237,6,There,O
166237,6,was,O
166237,6,some,O
166237,6,multifocal,O
166237,6,slowing,O
166237,6,admixed,O
166237,6,to,O
166237,6,the,O
166237,6,waking,O
166237,6,background,O
166237,6,",",O
166237,6,but,O
166237,6,this,O
166237,6,would,O
166237,6,be,O
166237,6,assessed,O
166237,6,better,O
166237,6,through,O
166237,6,routine,O
166237,6,EEG,O
166237,6,tracings,O
166237,6,.,O
166237,6,There,O
166237,6,were,O
166237,6,no,O
166237,6,areas,O
166237,6,of,O
166237,6,fixed,O
166237,6,focal,O
166237,6,slowing,O
166237,6,",",O
166237,6,and,O
166237,6,there,O
166237,6,were,O
166237,6,no,O
166237,6,epileptiform,O
166237,6,features,O
166237,6,.,O
166237,6,.,O
166237,6,(,O
166237,6,[,O
166237,6,**2186-10-20**,O
166237,6,],O
166237,6,),O
166237,6,:,O
166237,6,Chest,O
166237,6,X-ray,O
166237,6,IMPRESSION,O
166237,6,:,O
166237,6,Improving,O
166237,6,right,O
166237,6,lower,O
166237,6,lobe,O
166237,6,opacity,O
166237,6,.,O
166237,6,.,O
166237,6,(,O
166237,6,[,O
166237,6,**2186-10-20**,O
166237,6,],O
166237,6,),O
166237,6,:,O
166237,6,Transthoracic,O
166237,6,Echo,O
166237,6,:,O
166237,6,The,O
166237,6,left,O
166237,6,atrium,O
166237,6,is,O
166237,6,moderately,O
166237,6,dilated,O
166237,6,.,O
166237,6,There,O
166237,6,is,O
166237,6,mild,O
166237,6,symmetric,O
166237,6,left,O
166237,6,ventricular,O
166237,6,hypertrophy,O
166237,6,with,O
166237,6,normal,O
166237,6,cavity,O
166237,6,size,O
166237,6,and,O
166237,6,regional/global,O
166237,6,systolic,O
166237,6,function,O
166237,6,(,O
166237,6,LVEF,O
166237,6,>,O
166237,6,55,O
166237,6,%,O
166237,6,),O
166237,6,.,O
166237,6,Right,O
166237,6,ventricular,O
166237,6,chamber,O
166237,6,size,O
166237,6,and,O
166237,6,free,O
166237,6,wall,O
166237,6,motion,O
166237,6,are,O
166237,6,normal,O
166237,6,.,O
166237,6,The,O
166237,6,aortic,O
166237,6,valve,O
166237,6,leaflets,O
166237,6,(,O
166237,6,3,O
166237,6,),O
166237,6,are,O
166237,6,mildly,O
166237,6,thickened,O
166237,6,but,O
166237,6,aortic,O
166237,6,stenosis,O
166237,6,is,O
166237,6,not,O
166237,6,present,O
166237,6,.,O
166237,6,No,O
166237,6,aortic,O
166237,6,regurgitation,O
166237,6,is,O
166237,6,seen,O
166237,6,.,O
166237,6,The,O
166237,6,mitral,O
166237,6,valve,O
166237,6,leaflets,O
166237,6,are,O
166237,6,mildly,O
166237,6,thickened,O
166237,6,.,O
166237,6,Trivial,O
166237,6,mitral,O
166237,6,regurgitation,O
166237,6,is,O
166237,6,seen,O
166237,6,.,O
166237,6,The,O
166237,6,pulmonary,O
166237,6,artery,O
166237,6,systolic,O
166237,6,pressure,O
166237,6,could,O
166237,6,not,O
166237,6,be,O
166237,6,determined,O
166237,6,.,O
166237,6,There,O
166237,6,is,O
166237,6,no,O
166237,6,pericardial,O
166237,6,effusion,O
166237,6,.,O
166237,6,IMPRESSION,O
166237,6,:,O
166237,6,Mild,O
166237,6,symmetric,O
166237,7,left,O
166237,7,ventricular,O
166237,7,hypertrophy,O
166237,7,with,O
166237,7,preserved,O
166237,7,global,O
166237,7,and,O
166237,7,regional,O
166237,7,systolic,O
166237,7,function,O
166237,7,.,O
166237,7,.,O
166237,7,(,O
166237,7,[,O
166237,7,**2186-10-22**,O
166237,7,],O
166237,7,),O
166237,7,:,O
166237,7,EKG,O
166237,7,:,O
166237,7,Artifact,O
166237,7,is,O
166237,7,present,O
166237,7,.,O
166237,7,Probable,O
166237,7,sinus,O
166237,7,rhythm,O
166237,7,.,O
166237,7,Left,O
166237,7,axis,O
166237,7,deviation,O
166237,7,.,O
166237,7,Left,O
166237,7,anterior,O
166237,7,fascicular,O
166237,7,block,O
166237,7,.,O
166237,7,There,O
166237,7,is,O
166237,7,an,O
166237,7,early,O
166237,7,transition,O
166237,7,which,O
166237,7,is,O
166237,7,non-specific,O
166237,7,with,O
166237,7,subsequent,O
166237,7,loss,O
166237,7,of,O
166237,7,anterolateral,O
166237,7,R,O
166237,7,waves,O
166237,7,associated,O
166237,7,with,O
166237,7,anterior,O
166237,7,and,O
166237,7,anterolateral,O
166237,7,ST-T,O
166237,7,wave,O
166237,7,changes,O
166237,7,consistent,O
166237,7,with,O
166237,7,probable,O
166237,7,myocardial,O
166237,7,infarction,O
166237,7,.,O
166237,7,Left,O
166237,7,ventricular,O
166237,7,hypertrophy,O
166237,7,with,O
166237,7,associated,O
166237,7,ST-T,O
166237,7,wave,O
166237,7,changes,O
166237,7,.,O
166237,7,Incomplete,O
166237,7,right,O
166237,7,bundle-branch,O
166237,7,block,O
166237,7,.,O
166237,7,Compared,O
166237,7,to,O
166237,7,the,O
166237,7,prior,O
166237,7,tracing,O
166237,7,right,O
166237,7,bundle-branch,O
166237,7,block,O
166237,7,is,O
166237,7,now,O
166237,7,incomplete,O
166237,7,.,O
166237,7,.,O
166237,7,(,O
166237,7,[,O
166237,7,**2186-10-26**,O
166237,7,],O
166237,7,),O
166237,7,:,O
166237,7,Liver,O
166237,7,Ultrasound,O
166237,7,IMPRESSION,O
166237,7,:,O
166237,7,1,O
166237,7,.,O
166237,7,Findings,O
166237,7,are,O
166237,7,suspicious,O
166237,7,for,O
166237,7,acute,O
166237,7,cholecystitis,O
166237,7,and,O
166237,7,possible,O
166237,7,focal,O
166237,7,necrosis,O
166237,7,and,O
166237,7,perforation,O
166237,7,of,O
166237,7,the,O
166237,7,gallbladder,O
166237,7,wall,O
166237,7,.,O
166237,7,2,O
166237,7,.,O
166237,7,Right,O
166237,7,renal,O
166237,7,cysts,O
166237,7,.,O
166237,7,.,O
166237,7,(,O
166237,7,[,O
166237,7,**2186-10-26**,O
166237,7,],O
166237,7,),O
166237,7,:,O
166237,7,CT,O
166237,7,Pelvis/Abdomen/Chest,O
166237,7,:,O
166237,7,IMPRESSION,O
166237,7,:,O
166237,7,1,O
166237,7,.,O
166237,7,Small,O
166237,7,amount,O
166237,7,of,O
166237,7,free,O
166237,7,fluid,O
166237,7,in,O
166237,7,deep,O
166237,7,pelvis,O
166237,7,posterior,O
166237,7,to,O
166237,7,the,O
166237,7,rectum,O
166237,7,and,O
166237,7,anterior,O
166237,7,to,O
166237,7,the,O
166237,7,sacrum,O
166237,7,",",O
166237,7,without,O
166237,7,fluid,O
166237,7,collection,O
166237,7,or,O
166237,7,free,O
166237,7,air,O
166237,7,.,O
166237,7,Diverticulosis,O
166237,7,",",O
166237,7,without,O
166237,7,evidence,O
166237,7,of,O
166237,7,diverticulitis,O
166237,7,.,O
166237,7,Atelectasis,O
166237,7,and,O
166237,7,patchy,O
166237,7,opacities,O
166237,7,in,O
166237,7,the,O
166237,7,lungs,O
166237,7,",",O
166237,7,without,O
166237,7,discrete,O
166237,7,consolidation,O
166237,7,suggestive,O
166237,7,of,O
166237,7,pneumonia,O
166237,7,.,O
166237,7,2,O
166237,7,.,O
166237,7,Renal,O
166237,7,cysts,O
166237,7,.,O
166237,7,3,O
166237,7,.,O
166237,7,Nonspecific,O
166237,7,fluid-filled,O
166237,7,distended,O
166237,7,second,O
166237,7,portion,O
166237,7,of,O
166237,7,duodenum,O
166237,7,surrounded,O
166237,7,by,O
166237,7,mild,O
166237,7,fat,O
166237,7,stranding,O
166237,7,",",O
166237,7,with,O
166237,7,slight,O
166237,7,fat,O
166237,7,stranding,O
166237,7,surrounding,O
166237,7,the,O
166237,7,pancreatic,O
166237,7,head,O
166237,7,.,O
166237,7,The,O
166237,7,finding,O
166237,7,is,O
166237,7,nonspecific,O
166237,7,;,O
166237,7,however,O
166237,7,",",O
166237,7,in,O
166237,7,this,O
166237,7,patient,O
166237,7,with,O
166237,7,elevated,O
166237,7,white,O
166237,7,blood,O
166237,7,cell,O
166237,7,",",O
166237,7,duodenitis,O
166237,7,or,O
166237,7,early,O
166237,7,pancreatitis,O
166237,7,can,O
166237,7,not,O
166237,7,be,O
166237,7,excluded,O
166237,7,.,O
166237,7,Please,O
166237,7,correlate,O
166237,7,with,O
166237,7,laboratory,O
166237,7,values,O
166237,7,.,O
166237,7,4,O
166237,7,.,O
166237,7,Small,O
166237,7,amount,O
166237,7,of,O
166237,7,pericholecystic,O
166237,7,fluid,O
166237,7,with,O
166237,7,questionable,O
166237,7,sludge,O
166237,7,.,O
166237,7,If,O
166237,7,indicated,O
166237,7,",",O
166237,7,please,O
166237,7,consider,O
166237,7,gallbladder,O
166237,7,ultrasound,O
166237,7,.,O
166237,7,.,O
166237,7,(,O
166237,7,[,O
166237,7,**2186-10-28**,O
166237,7,],O
166237,7,),O
166237,7,:,O
166237,7,CT,O
166237,7,Abdomen/Pelvis,O
166237,7,:,O
166237,7,IMPRESSION,O
166237,7,:,O
166237,7,Percutaneous,O
166237,7,gallbladder,O
166237,7,drain,O
166237,7,contained,O
166237,7,within,O
166237,7,the,O
166237,7,gallbladder,O
166237,7,.,O
166237,7,The,O
166237,7,gallbladder,O
166237,7,is,O
166237,7,decompressed,O
166237,7,.,O
166237,7,No,O
166237,7,perihepatic,O
166237,7,or,O
166237,7,intra-abdominal,O
166237,7,fluid,O
166237,7,or,O
166237,7,hemorrhage,O
166237,8,is,O
166237,8,identified,O
166237,8,.,O
166237,8,Stable,O
166237,8,stranding,O
166237,8,surrounding,O
166237,8,the,O
166237,8,second,O
166237,8,and,O
166237,8,third,O
166237,8,portions,O
166237,8,of,O
166237,8,the,O
166237,8,duodenum,O
166237,8,and,O
166237,8,pancreatic,O
166237,8,head,O
166237,8,.,O
166237,8,(,O
166237,8,[,O
166237,8,**2186-10-30**,O
166237,8,],O
166237,8,),O
166237,8,:,O
166237,8,Ultrasound,O
166237,8,of,O
166237,8,lower,O
166237,8,extremities,O
166237,8,:,O
166237,8,IMPRESSION,O
166237,8,:,O
166237,8,No,O
166237,8,evidence,O
166237,8,for,O
166237,8,deep,O
166237,8,venous,O
166237,8,thrombus,O
166237,8,in,O
166237,8,bilateral,O
166237,8,lower,O
166237,8,extremities,O
166237,8,.,O
166237,8,.,O
166237,8,(,O
166237,8,[,O
166237,8,**2186-10-30**,O
166237,8,],O
166237,8,),O
166237,8,:,O
166237,8,Head,O
166237,8,CT,O
166237,8,w/out,O
166237,8,contrast,O
166237,8,:,O
166237,8,IMPRESSION,O
166237,8,:,O
166237,8,Aerosolized,O
166237,8,secretions,O
166237,8,in,O
166237,8,the,O
166237,8,sphenoid,O
166237,8,sinus,O
166237,8,and,O
166237,8,increased,O
166237,8,opacity,O
166237,8,in,O
166237,8,the,O
166237,8,right,O
166237,8,frontoethmoid,O
166237,8,recess,O
166237,8,.,O
166237,8,Please,O
166237,8,correlate,O
166237,8,clinically,O
166237,8,.,O
166237,8,Otherwise,O
166237,8,",",O
166237,8,no,O
166237,8,significant,O
166237,8,change,O
166237,8,",",O
166237,8,including,O
166237,8,no,O
166237,8,evidence,O
166237,8,of,O
166237,8,intracranial,O
166237,8,hemorrhage,O
166237,8,or,O
166237,8,large,O
166237,8,recent,O
166237,8,infarction,O
166237,8,.,O
166237,8,.,O
166237,8,(,O
166237,8,[,O
166237,8,**2186-11-3**,O
166237,8,],O
166237,8,),O
166237,8,:,O
166237,8,Gallbladder,O
166237,8,scan,O
166237,8,:,O
166237,8,IMPRESSION,O
166237,8,:,O
166237,8,1,O
166237,8,.,O
166237,8,Prompt,O
166237,8,filling,O
166237,8,of,O
166237,8,the,O
166237,8,gallbladder,O
166237,8,and,O
166237,8,exit,O
166237,8,into,O
166237,8,the,O
166237,8,duodenum,O
166237,8,.,O
166237,8,2,O
166237,8,.,O
166237,8,Patent,O
166237,8,cholecystostomy,O
166237,8,drainage,O
166237,8,tube,O
166237,8,.,O
166237,8,3,O
166237,8,.,O
166237,8,No,O
166237,8,evidence,O
166237,8,of,O
166237,8,leak,O
166237,8,outside,O
166237,8,of,O
166237,8,the,O
166237,8,gallbladder,O
166237,8,.,O
166237,8,.,O
166237,8,(,O
166237,8,[,O
166237,8,**2186-11-5**,O
166237,8,],O
166237,8,),O
166237,8,:,O
166237,8,Ultrasound,O
166237,8,of,O
166237,8,abdomen,O
166237,8,:,O
166237,8,IMPRESSION,O
166237,8,:,O
166237,8,1,O
166237,8,.,O
166237,8,No,O
166237,8,evidence,O
166237,8,of,O
166237,8,main,O
166237,8,portal,O
166237,8,vein,O
166237,8,thrombosis,O
166237,8,.,O
166237,8,The,O
166237,8,more,O
166237,8,distal,O
166237,8,branches,O
166237,8,of,O
166237,8,the,O
166237,8,portal,O
166237,8,vein,O
166237,8,were,O
166237,8,not,O
166237,8,interrogated,O
166237,8,.,O
166237,8,If,O
166237,8,there,O
166237,8,is,O
166237,8,further,O
166237,8,clinical,O
166237,8,concern,O
166237,8,",",O
166237,8,additional,O
166237,8,dedicated,O
166237,8,views,O
166237,8,of,O
166237,8,the,O
166237,8,portal,O
166237,8,vein,O
166237,8,vasculature,O
166237,8,can,O
166237,8,be,O
166237,8,performed,O
166237,8,.,O
166237,8,2,O
166237,8,.,O
166237,8,Nonvisualization,O
166237,8,of,O
166237,8,the,O
166237,8,gallbladder,O
166237,8,",",O
166237,8,likley,O
166237,8,due,O
166237,8,to,O
166237,8,collapsed,O
166237,8,state,O
166237,8,.,O
166237,8,3,O
166237,8,.,O
166237,8,Stable,O
166237,8,simple-appearing,O
166237,8,right,O
166237,8,renal,O
166237,8,cysts,O
166237,8,.,O
166237,8,.,O
166237,8,(,O
166237,8,[,O
166237,8,**2186-11-27**,O
166237,8,],O
166237,8,),O
166237,8,Ultrasound,O
166237,8,of,O
166237,8,thyroid,O
166237,8,:,O
166237,8,IMPRESSION,O
166237,8,:,O
166237,8,1,O
166237,8,.,O
166237,8,Completely,O
166237,8,absent,O
166237,8,right,O
166237,8,lobe,O
166237,8,of,O
166237,8,the,O
166237,8,thyroid,O
166237,8,.,O
166237,8,Small,O
166237,8,remnant,O
166237,8,of,O
166237,8,the,O
166237,8,left,O
166237,8,thyroid,O
166237,8,lobe,O
166237,8,is,O
166237,8,unchanged,O
166237,8,compared,O
166237,8,to,O
166237,8,the,O
166237,8,prior,O
166237,8,study,O
166237,8,.,O
166237,8,.,O
166237,8,Brief,O
166237,8,Hospital,O
166237,8,Course,O
166237,8,:,O
166237,8,Patient,O
166237,8,is,O
166237,8,an,O
166237,8,84,O
166237,8,year,O
166237,8,old,O
166237,8,female,O
166237,8,with,O
166237,8,mild,O
166237,8,dementia,O
166237,8,",",O
166237,8,hypertension,O
166237,8,",",O
166237,8,diabetes,O
166237,8,mellitus,O
166237,8,type,O
166237,8,two,O
166237,8,",",O
166237,8,and,O
166237,8,bipolar,O
166237,8,disease,O
166237,8,",",O
166237,8,who,O
166237,8,presented,O
166237,8,on,O
166237,8,[,O
166237,8,**2186-10-11**,O
166237,8,],O
166237,8,from,O
166237,8,[,O
166237,8,**Hospital3,O
166237,8,**,O
166237,8,],O
166237,8,with,O
166237,8,failure,O
166237,8,to,O
166237,8,thrive,O
166237,8,",",O
166237,8,and,O
166237,8,was,O
166237,8,being,O
166237,8,worked,O
166237,8,up,O
166237,8,for,O
166237,8,renal,O
166237,8,failure,O
166237,8,and,O
166237,8,balancing,O
166237,9,hypertension,B-Drug
166237,9,medications,I-Drug
166237,9,",",O
166237,9,who,O
166237,9,was,O
166237,9,found,O
166237,9,by,O
166237,9,nursing,O
166237,9,staff,O
166237,9,to,O
166237,9,be,O
166237,9,',O
166237,9,unresponsive,B-ADE
166237,9,',O
166237,9,with,O
166237,9,no,B-ADE
166237,9,breathing,I-ADE
166237,9,or,I-ADE
166237,9,radial,I-ADE
166237,9,pulse,I-ADE
166237,9,for,I-ADE
166237,9,20,I-ADE
166237,9,seconds,I-ADE
166237,9,and,O
166237,9,transferred,O
166237,9,to,O
166237,9,intensive,O
166237,9,care,O
166237,9,unit,O
166237,9,.,O
166237,9,.,O
166237,9,#,O
166237,9,Unresponsive,O
166237,9,episodes,O
166237,9,-,O
166237,9,Patient,O
166237,9,had,O
166237,9,initial,O
166237,9,episode,O
166237,9,of,O
166237,9,unresponsiveness,O
166237,9,",",O
166237,9,and,O
166237,9,additional,O
166237,9,episodes,O
166237,9,witnessed,O
166237,9,by,O
166237,9,the,O
166237,9,intensive,O
166237,9,care,O
166237,9,team,O
166237,9,.,O
166237,9,There,O
166237,9,was,O
166237,9,concern,O
166237,9,for,O
166237,9,seizure,O
166237,9,activity,O
166237,9,",",O
166237,9,given,O
166237,9,complete,O
166237,9,unresponsiveness,O
166237,9,to,O
166237,9,verbal,O
166237,9,and,O
166237,9,tactile,O
166237,9,stimuli,O
166237,9,",",O
166237,9,then,O
166237,9,confusion,O
166237,9,and,O
166237,9,return,O
166237,9,to,O
166237,9,baseline,O
166237,9,after,O
166237,9,episode,O
166237,9,.,O
166237,9,Given,O
166237,9,her,O
166237,9,diabetes,O
166237,9,and,O
166237,9,her,O
166237,9,labile,O
166237,9,blood,O
166237,9,pressure,O
166237,9,",",O
166237,9,autonomic,O
166237,9,seizures,O
166237,9,were,O
166237,9,of,O
166237,9,particular,O
166237,9,concern,O
166237,9,",",O
166237,9,as,O
166237,9,was,O
166237,9,complete,O
166237,9,heart,O
166237,9,block,O
166237,9,(,O
166237,9,given,O
166237,9,known,O
166237,9,RBBB,O
166237,9,with,O
166237,9,LAFB,O
166237,9,),O
166237,9,however,O
166237,9,telemetry,O
166237,9,tracings,O
166237,9,remained,O
166237,9,within,O
166237,9,normal,O
166237,9,limits,O
166237,9,.,O
166237,9,It,O
166237,9,was,O
166237,9,also,O
166237,9,concerning,O
166237,9,that,O
166237,9,her,O
166237,9,medications,O
166237,9,could,O
166237,9,be,O
166237,9,playing,O
166237,9,role,O
166237,9,.,O
166237,9,She,O
166237,9,was,O
166237,9,monitored,O
166237,9,on,O
166237,9,telemetry,O
166237,9,which,O
166237,9,was,O
166237,9,unrevealing,O
166237,9,for,O
166237,9,a,O
166237,9,cause,O
166237,9,",",O
166237,9,a,O
166237,9,transthoracic,O
166237,9,echo,O
166237,9,did,O
166237,9,not,O
166237,9,reveal,O
166237,9,clear,O
166237,9,cause,O
166237,9,",",O
166237,9,nor,O
166237,9,did,O
166237,9,continuous,O
166237,9,EEG,O
166237,9,monitoring,O
166237,9,.,O
166237,9,Several,O
166237,9,of,O
166237,9,her,O
166237,9,blood,B-Drug
166237,9,pressure,I-Drug
166237,9,medications,I-Drug
166237,9,were,O
166237,9,held,O
166237,9,to,O
166237,9,avoid,O
166237,9,hypotensive,B-ADE
166237,9,episodes,I-ADE
166237,9,",",O
166237,9,which,O
166237,9,ultimately,O
166237,9,felt,O
166237,9,to,O
166237,9,be,O
166237,9,the,O
166237,9,a,O
166237,9,large,O
166237,9,part,O
166237,9,of,O
166237,9,the,O
166237,9,cause,O
166237,9,.,O
166237,9,She,O
166237,9,had,O
166237,9,no,O
166237,9,further,O
166237,9,episodes,O
166237,9,after,O
166237,9,her,O
166237,9,first,O
166237,9,transfer,O
166237,9,out,O
166237,9,of,O
166237,9,the,O
166237,9,intensive,O
166237,9,care,O
166237,9,unit,O
166237,9,on,O
166237,9,[,O
166237,9,**2186-10-17**,O
166237,9,],O
166237,9,.,O
166237,9,.,O
166237,9,#,O
166237,9,Hypertension,O
166237,9,-,O
166237,9,Patient,O
166237,9,has,O
166237,9,historically,O
166237,9,difficult,O
166237,9,to,O
166237,9,control,O
166237,9,blood,O
166237,9,pressure,O
166237,9,",",O
166237,9,with,O
166237,9,typical,O
166237,9,systolic,O
166237,9,blood,O
166237,9,pressure,O
166237,9,of,O
166237,9,180,O
166237,9,'s,O
166237,9,as,O
166237,9,an,O
166237,9,outpatient,O
166237,9,.,O
166237,9,An,O
166237,9,abdominal,O
166237,9,bruit,O
166237,9,was,O
166237,9,appreciated,O
166237,9,on,O
166237,9,exam,O
166237,9,.,O
166237,9,A,O
166237,9,renal,O
166237,9,ultarsound,O
166237,9,showed,O
166237,9,bilateral,O
166237,9,flow,O
166237,9,with,O
166237,9,doplers,O
166237,9,.,O
166237,9,Imaging,O
166237,9,with,O
166237,9,captopril,B-Drug
166237,9,was,O
166237,9,obtained,O
166237,9,to,O
166237,9,further,O
166237,9,evaluate,O
166237,9,for,O
166237,9,renal,O
166237,9,artery,O
166237,9,stenosis,O
166237,9,",",O
166237,9,and,O
166237,9,was,O
166237,9,within,O
166237,9,normal,O
166237,9,limits,O
166237,9,.,O
166237,9,A,O
166237,9,work,O
166237,9,up,O
166237,9,for,O
166237,9,other,O
166237,9,secondary,O
166237,9,causes,O
166237,9,was,O
166237,9,initiated,O
166237,9,",",O
166237,9,including,O
166237,9,hyperaldosterone,O
166237,9,",",O
166237,9,hyper-renin,O
166237,9,",",O
166237,9,hyper-ACTH,O
166237,9,",",O
166237,9,and,O
166237,9,pheochromocytoma,O
166237,9,.,O
166237,9,Her,O
166237,9,work,O
166237,9,up,O
166237,9,revealed,O
166237,9,slightly,O
166237,9,elevated,O
166237,9,normetanephrine,O
166237,9,in,O
166237,9,serum,O
166237,9,and,O
166237,9,urine,O
166237,9,",",O
166237,9,as,O
166237,9,well,O
166237,9,as,O
166237,9,very,O
166237,9,mildly,O
166237,9,elevated,O
166237,9,epinephrine,B-Drug
166237,9,",",O
166237,9,norepinephrine,B-Drug
166237,10,",",O
166237,10,dopamine,B-Drug
166237,10,",",O
166237,10,and,O
166237,10,catecholamines,O
166237,10,;,O
166237,10,it,O
166237,10,was,O
166237,10,not,O
166237,10,felt,O
166237,10,that,O
166237,10,these,O
166237,10,were,O
166237,10,consistent,O
166237,10,with,O
166237,10,a,O
166237,10,pheochromocytoma,O
166237,10,.,O
166237,10,An,O
166237,10,AM,B-ADE
166237,10,cortisol,I-ADE
166237,10,was,I-ADE
166237,10,found,I-ADE
166237,10,to,I-ADE
166237,10,be,I-ADE
166237,10,elevated,I-ADE
166237,10,and,O
166237,10,resistant,O
166237,10,to,O
166237,10,supression,O
166237,10,by,O
166237,10,1mg,O
166237,10,dexamethasone,B-Drug
166237,10,overnight,O
166237,10,.,O
166237,10,Because,O
166237,10,of,O
166237,10,that,O
166237,10,",",O
166237,10,a,O
166237,10,CT,O
166237,10,abdomen/pelvis,O
166237,10,was,O
166237,10,obtained,O
166237,10,on,O
166237,10,[,O
166237,10,**2186-10-26**,O
166237,10,],O
166237,10,to,O
166237,10,look,O
166237,10,for,O
166237,10,source,O
166237,10,of,O
166237,10,Cushings,O
166237,10,syndrome,O
166237,10,or,O
166237,10,ectopic,O
166237,10,ACTH,O
166237,10,secretion,O
166237,10,--,O
166237,10,it,O
166237,10,showed,O
166237,10,inflammation,O
166237,10,around,O
166237,10,the,O
166237,10,duodenum,O
166237,10,and,O
166237,10,head,O
166237,10,of,O
166237,10,the,O
166237,10,pancreas,O
166237,10,but,O
166237,10,no,O
166237,10,adrenal,O
166237,10,masses,O
166237,10,.,O
166237,10,.,O
166237,10,Her,O
166237,10,blood,B-Drug
166237,10,pressure,I-Drug
166237,10,medications,I-Drug
166237,10,were,O
166237,10,slowly,O
166237,10,re-introduced,O
166237,10,",",O
166237,10,to,O
166237,10,avoid,O
166237,10,hypotension,O
166237,10,",",O
166237,10,with,O
166237,10,goal,O
166237,10,systolic,O
166237,10,blood,O
166237,10,pressure,O
166237,10,greater,O
166237,10,than,O
166237,10,130,O
166237,10,'s,O
166237,10,to,O
166237,10,140,O
166237,10,'s,O
166237,10,.,O
166237,10,.,O
166237,10,At,O
166237,10,time,O
166237,10,of,O
166237,10,discharge,O
166237,10,",",O
166237,10,her,O
166237,10,blood,B-Drug
166237,10,pressure,I-Drug
166237,10,medications,I-Drug
166237,10,were,O
166237,10,:,O
166237,10,-,O
166237,10,Metoprolol,B-Drug
166237,10,100,O
166237,10,mg,O
166237,10,q8,O
166237,10,hours,O
166237,10,-,O
166237,10,Clonidine,B-Drug
166237,10,TTS,O
166237,10,2,O
166237,10,patch,O
166237,10,weekly,O
166237,10,-,O
166237,10,Captopril,B-Drug
166237,10,75,O
166237,10,mg,O
166237,10,q8,O
166237,10,hours,O
166237,10,.,O
166237,10,#,O
166237,10,Arrythmias,B-Reason
166237,10,:,O
166237,10,Cardiology,O
166237,10,was,O
166237,10,consulted,O
166237,10,early,O
166237,10,in,O
166237,10,her,O
166237,10,stay,O
166237,10,after,O
166237,10,episodes,O
166237,10,of,O
166237,10,V-,O
166237,10,[,O
166237,10,**Last,O
166237,10,Name,O
166237,10,(,O
166237,10,LF,O
166237,10,),O
166237,10,**,O
166237,10,],O
166237,10,",",O
166237,10,[,O
166237,10,**First,O
166237,10,Name3,O
166237,10,(,O
166237,10,LF,O
166237,10,),O
166237,10,**,O
166237,10,],O
166237,10,",",O
166237,10,and,O
166237,10,PVCs,O
166237,10,.,O
166237,10,It,O
166237,10,was,O
166237,10,recommended,O
166237,10,to,O
166237,10,continue,O
166237,10,rate,B-Reason
166237,10,control,I-Reason
166237,10,metoprolol,O
166237,10,",",O
166237,10,as,O
166237,10,well,O
166237,10,as,O
166237,10,continue,O
166237,10,her,O
166237,10,ACE-I,B-Drug
166237,10,.,O
166237,10,Electrophysiology,O
166237,10,was,O
166237,10,asked,O
166237,10,to,O
166237,10,see,O
166237,10,patient,O
166237,10,again,O
166237,10,on,O
166237,10,[,O
166237,10,**2186-10-22**,O
166237,10,],O
166237,10,for,O
166237,10,repeated,O
166237,10,episodes,O
166237,10,of,O
166237,10,V-,O
166237,10,[,O
166237,10,**Year,O
166237,10,(,O
166237,10,4,O
166237,10,digits,O
166237,10,),O
166237,10,**,O
166237,10,],O
166237,10,.,O
166237,10,At,O
166237,10,that,O
166237,10,time,O
166237,10,",",O
166237,10,amiodarone,B-Drug
166237,10,was,O
166237,10,initiated,O
166237,10,at,O
166237,10,200,O
166237,10,TID,O
166237,10,",",O
166237,10,tapered,O
166237,10,to,O
166237,10,200,O
166237,10,mg,O
166237,10,[,O
166237,10,**Hospital1,O
166237,10,**,O
166237,10,],O
166237,10,on,O
166237,10,[,O
166237,10,**11-1**,O
166237,10,],O
166237,10,",",O
166237,10,and,O
166237,10,finally,O
166237,10,continued,O
166237,10,at,O
166237,10,200,O
166237,10,mg,O
166237,10,daily,O
166237,10,since,O
166237,10,[,O
166237,10,**2186-11-14**,O
166237,10,],O
166237,10,.,O
166237,10,She,O
166237,10,had,O
166237,10,no,O
166237,10,further,O
166237,10,arrythmias,O
166237,10,noted,O
166237,10,.,O
166237,10,.,O
166237,10,#,O
166237,10,Renal,O
166237,10,insufficiency,O
166237,10,-,O
166237,10,Upon,O
166237,10,admission,O
166237,10,",",O
166237,10,she,O
166237,10,had,O
166237,10,worsening,O
166237,10,of,O
166237,10,her,O
166237,10,renal,O
166237,10,function,O
166237,10,with,O
166237,10,a,O
166237,10,creatinine,O
166237,10,to,O
166237,10,1.7,O
166237,10,.,O
166237,10,It,O
166237,10,was,O
166237,10,felt,O
166237,10,that,O
166237,10,her,O
166237,10,renal,B-Reason
166237,10,insufficiency,I-Reason
166237,10,was,O
166237,10,pre-renal,O
166237,10,in,O
166237,10,nature,O
166237,10,",",O
166237,10,and,O
166237,10,she,O
166237,10,was,O
166237,10,given,O
166237,10,gentle,O
166237,10,intravenous,O
166237,10,fluids,B-Drug
166237,10,.,O
166237,10,It,O
166237,10,was,O
166237,10,thought,O
166237,10,she,O
166237,10,had,O
166237,10,an,O
166237,10,element,O
166237,11,of,O
166237,11,diabetic,O
166237,11,nephropathy,O
166237,11,as,O
166237,11,well,O
166237,11,.,O
166237,11,The,O
166237,11,renal,O
166237,11,team,O
166237,11,was,O
166237,11,consulted,O
166237,11,and,O
166237,11,assisted,O
166237,11,with,O
166237,11,management,O
166237,11,of,O
166237,11,her,O
166237,11,care,O
166237,11,.,O
166237,11,Her,O
166237,11,creatinine,O
166237,11,rose,O
166237,11,to,O
166237,11,2.0,O
166237,11,at,O
166237,11,its,O
166237,11,peak,O
166237,11,",",O
166237,11,coinciding,O
166237,11,with,O
166237,11,her,O
166237,11,hypotensive,O
166237,11,episodes,O
166237,11,.,O
166237,11,At,O
166237,11,time,O
166237,11,of,O
166237,11,discharge,O
166237,11,",",O
166237,11,her,O
166237,11,renal,O
166237,11,function,O
166237,11,was,O
166237,11,stable,O
166237,11,at,O
166237,11,0.8-1.2,O
166237,11,",",O
166237,11,and,O
166237,11,she,O
166237,11,continued,O
166237,11,to,O
166237,11,put,O
166237,11,out,O
166237,11,good,O
166237,11,amounts,O
166237,11,of,O
166237,11,urine..,O
166237,11,.,O
166237,11,#,O
166237,11,Type,B-Reason
166237,11,two,I-Reason
166237,11,diabetes,I-Reason
166237,11,mellitus,I-Reason
166237,11,-,O
166237,11,Patient,O
166237,11,was,O
166237,11,on,O
166237,11,glipizide,B-Drug
166237,11,at,O
166237,11,home,O
166237,11,",",O
166237,11,however,O
166237,11,with,O
166237,11,her,O
166237,11,worsening,O
166237,11,renal,O
166237,11,function,O
166237,11,and,O
166237,11,very,O
166237,11,little,O
166237,11,PO,O
166237,11,intake,O
166237,11,",",O
166237,11,a,O
166237,11,sliding,O
166237,11,scale,O
166237,11,of,O
166237,11,insulin,B-Drug
166237,11,was,O
166237,11,started,O
166237,11,",",O
166237,11,and,O
166237,11,basal,B-Drug
166237,11,insulin,I-Drug
166237,11,was,O
166237,11,added,O
166237,11,as,O
166237,11,needed,O
166237,11,.,O
166237,11,At,O
166237,11,time,O
166237,11,of,O
166237,11,discharge,O
166237,11,",",O
166237,11,she,O
166237,11,was,O
166237,11,on,O
166237,11,30,O
166237,11,units,O
166237,11,of,O
166237,11,lantus,B-Drug
166237,11,in,O
166237,11,addition,O
166237,11,to,O
166237,11,a,O
166237,11,humalong,B-Drug
166237,11,sliding,O
166237,11,scale,O
166237,11,.,O
166237,11,.,O
166237,11,#,O
166237,11,Hypothyroidism,B-Reason
166237,11,-,O
166237,11,Patient,O
166237,11,has,O
166237,11,history,O
166237,11,of,O
166237,11,thyroid,O
166237,11,carcinoma,O
166237,11,and,O
166237,11,is,O
166237,11,status-post,O
166237,11,thyroidectomy,O
166237,11,.,O
166237,11,At,O
166237,11,time,O
166237,11,of,O
166237,11,admission,O
166237,11,",",O
166237,11,her,O
166237,11,TSH,O
166237,11,was,O
166237,11,very,O
166237,11,suppressed,O
166237,11,",",O
166237,11,but,O
166237,11,her,O
166237,11,free,O
166237,11,T4,O
166237,11,level,O
166237,11,was,O
166237,11,within,O
166237,11,normal,O
166237,11,limits,O
166237,11,.,O
166237,11,Her,O
166237,11,TSH,O
166237,11,rose,O
166237,11,during,O
166237,11,her,O
166237,11,stay,O
166237,11,",",O
166237,11,peaking,O
166237,11,at,O
166237,11,32,O
166237,11,.,O
166237,11,Her,O
166237,11,T4,O
166237,11,studies,O
166237,11,were,O
166237,11,found,O
166237,11,to,O
166237,11,be,O
166237,11,low,O
166237,11,.,O
166237,11,Endocrine,O
166237,11,consultation,O
166237,11,was,O
166237,11,obtained,O
166237,11,to,O
166237,11,assist,O
166237,11,with,O
166237,11,management,O
166237,11,of,O
166237,11,her,O
166237,11,thyroid,O
166237,11,disease,O
166237,11,",",O
166237,11,especially,O
166237,11,with,O
166237,11,concurrent,O
166237,11,use,O
166237,11,of,O
166237,11,amiodarone,B-Drug
166237,11,and,O
166237,11,lithium,B-Drug
166237,11,.,O
166237,11,Her,O
166237,11,dose,O
166237,11,of,O
166237,11,levothyroxine,B-Drug
166237,11,was,O
166237,11,increased,O
166237,11,to,O
166237,11,300,O
166237,11,mcg,O
166237,11,for,O
166237,11,several,O
166237,11,days,O
166237,11,",",O
166237,11,then,O
166237,11,brought,O
166237,11,down,O
166237,11,to,O
166237,11,175,O
166237,11,mcg,O
166237,11,prior,O
166237,11,to,O
166237,11,discharge,O
166237,11,.,O
166237,11,Her,O
166237,11,TSH,O
166237,11,remained,O
166237,11,elevated,O
166237,11,(,O
166237,11,15,O
166237,11,),O
166237,11,on,O
166237,11,a,O
166237,11,subsequent,O
166237,11,check,O
166237,11,on,O
166237,11,[,O
166237,11,**12-13**,O
166237,11,],O
166237,11,.,O
166237,11,This,O
166237,11,was,O
166237,11,associated,O
166237,11,with,O
166237,11,a,O
166237,11,normal,O
166237,11,free,O
166237,11,T4,O
166237,11,(,O
166237,11,1.5,O
166237,11,),O
166237,11,.,O
166237,11,After,O
166237,11,discussion,O
166237,11,with,O
166237,11,endocrinology,O
166237,11,",",O
166237,11,it,O
166237,11,was,O
166237,11,felt,O
166237,11,that,O
166237,11,she,O
166237,11,may,O
166237,11,not,O
166237,11,be,O
166237,11,absorbing,O
166237,11,well,O
166237,11,and,O
166237,11,may,O
166237,11,be,O
166237,11,becoming,O
166237,11,progressively,O
166237,11,more,O
166237,11,hypothyroid,O
166237,11,.,O
166237,11,Her,O
166237,11,tube,O
166237,11,feeds,O
166237,11,should,O
166237,11,be,O
166237,11,held,O
166237,11,30,O
166237,11,minutes,O
166237,11,before,O
166237,11,and,O
166237,11,after,O
166237,11,administering,O
166237,11,synthroid,B-Drug
166237,11,;,O
166237,11,she,O
166237,11,should,O
166237,11,have,O
166237,11,her,O
166237,11,levels,O
166237,11,followed,O
166237,11,to,O
166237,11,ensure,O
166237,11,that,O
166237,11,this,O
166237,11,is,O
166237,11,effective,O
166237,11,.,O
166237,11,If,O
166237,11,she,O
166237,12,is,O
166237,12,still,O
166237,12,underreplaced,O
166237,12,",",O
166237,12,she,O
166237,12,may,O
166237,12,need,O
166237,12,to,O
166237,12,have,O
166237,12,IV,O
166237,12,levothyroxine,B-Drug
166237,12,.,O
166237,12,-,O
166237,12,Her,O
166237,12,thyroid,O
166237,12,function,O
166237,12,tests,O
166237,12,should,O
166237,12,be,O
166237,12,checked,O
166237,12,and,O
166237,12,followed,O
166237,12,up,O
166237,12,1-2,O
166237,12,weeks,O
166237,12,after,O
166237,12,discharge,O
166237,12,.,O
166237,12,-,O
166237,12,An,O
166237,12,ultrasound,O
166237,12,of,O
166237,12,her,O
166237,12,thyroid,O
166237,12,was,O
166237,12,checked,O
166237,12,to,O
166237,12,assess,O
166237,12,for,O
166237,12,any,O
166237,12,thyroid,O
166237,12,disease,O
166237,12,or,O
166237,12,cancer,O
166237,12,recurrence,O
166237,12,in,O
166237,12,light,O
166237,12,of,O
166237,12,her,O
166237,12,elevated,O
166237,12,TSH,O
166237,12,.,O
166237,12,The,O
166237,12,ultrasound,O
166237,12,was,O
166237,12,unchanged,O
166237,12,from,O
166237,12,prior,O
166237,12,studies,O
166237,12,.,O
166237,12,.,O
166237,12,#,O
166237,12,Upper,O
166237,12,gastrointestinal,O
166237,12,bleed,O
166237,12,:,O
166237,12,On,O
166237,12,[,O
166237,12,**2186-11-4**,O
166237,12,],O
166237,12,patient,O
166237,12,developed,O
166237,12,a,O
166237,12,decline,O
166237,12,in,O
166237,12,her,O
166237,12,hematocrit,O
166237,12,to,O
166237,12,19,O
166237,12,",",O
166237,12,with,O
166237,12,guaiac,O
166237,12,positive,O
166237,12,stools,O
166237,12,",",O
166237,12,then,O
166237,12,melena,O
166237,12,and,O
166237,12,bright,O
166237,12,red,O
166237,12,blood,O
166237,12,per,O
166237,12,rectum,O
166237,12,.,O
166237,12,She,O
166237,12,was,O
166237,12,transferred,O
166237,12,to,O
166237,12,the,O
166237,12,intensive,O
166237,12,care,O
166237,12,unit,O
166237,12,",",O
166237,12,and,O
166237,12,gastroenterology,O
166237,12,was,O
166237,12,consulted,O
166237,12,.,O
166237,12,An,O
166237,12,upper,O
166237,12,endoscopy,O
166237,12,revealed,O
166237,12,bleeding,B-Reason
166237,12,duodenal,I-Reason
166237,12,ulcers,I-Reason
166237,12,that,O
166237,12,were,O
166237,12,injected,O
166237,12,and,O
166237,12,cauterized,O
166237,12,.,O
166237,12,She,O
166237,12,required,O
166237,12,a,O
166237,12,total,O
166237,12,of,O
166237,12,9,O
166237,12,units,O
166237,12,of,O
166237,12,packed,B-Drug
166237,12,red,I-Drug
166237,12,blood,I-Drug
166237,12,cells,I-Drug
166237,12,during,O
166237,12,her,O
166237,12,intensive,O
166237,12,care,O
166237,12,stay,O
166237,12,.,O
166237,12,Her,O
166237,12,hematocrit,O
166237,12,remained,O
166237,12,relatively,O
166237,12,stable,O
166237,12,after,O
166237,12,her,O
166237,12,transfer,O
166237,12,back,O
166237,12,to,O
166237,12,the,O
166237,12,general,O
166237,12,floors,O
166237,12,on,O
166237,12,[,O
166237,12,**2186-11-8**,O
166237,12,],O
166237,12,",",O
166237,12,until,O
166237,12,[,O
166237,12,**2186-11-15**,O
166237,12,],O
166237,12,",",O
166237,12,at,O
166237,12,which,O
166237,12,time,O
166237,12,her,O
166237,12,hematocrit,O
166237,12,continued,O
166237,12,to,O
166237,12,drift,O
166237,12,downward,O
166237,12,and,O
166237,12,her,O
166237,12,stools,O
166237,12,were,O
166237,12,guaiac,O
166237,12,positive,O
166237,12,.,O
166237,12,Plans,O
166237,12,were,O
166237,12,made,O
166237,12,for,O
166237,12,a,O
166237,12,colonoscopy,O
166237,12,",",O
166237,12,however,O
166237,12,",",O
166237,12,in,O
166237,12,light,O
166237,12,of,O
166237,12,an,O
166237,12,additional,O
166237,12,hematocrit,O
166237,12,drop,O
166237,12,to,O
166237,12,20,O
166237,12,",",O
166237,12,a,O
166237,12,repeat,O
166237,12,endoscopy,O
166237,12,was,O
166237,12,completed,O
166237,12,on,O
166237,12,[,O
166237,12,**2186-11-17**,O
166237,12,],O
166237,12,",",O
166237,12,and,O
166237,12,a,O
166237,12,new,O
166237,12,third,O
166237,12,duodenal,O
166237,12,ulcer,O
166237,12,was,O
166237,12,noted,O
166237,12,which,O
166237,12,was,O
166237,12,also,O
166237,12,treated,O
166237,12,.,O
166237,12,She,O
166237,12,received,O
166237,12,two,O
166237,12,additional,O
166237,12,units,O
166237,12,of,O
166237,12,red,B-Drug
166237,12,blood,I-Drug
166237,12,cells,I-Drug
166237,12,.,O
166237,12,.,O
166237,12,Testing,O
166237,12,for,O
166237,12,h.,O
166237,12,pylori,O
166237,12,was,O
166237,12,negative,O
166237,12,",",O
166237,12,and,O
166237,12,gastrin,O
166237,12,levels,O
166237,12,were,O
166237,12,elevated,O
166237,12,;,O
166237,12,the,O
166237,12,elevated,B-ADE
166237,12,gastrin,I-ADE
166237,12,levels,I-ADE
166237,12,were,O
166237,12,expected,O
166237,12,in,O
166237,12,setting,O
166237,12,of,O
166237,12,PPI,B-Drug
166237,12,use,O
166237,12,",",O
166237,12,and,O
166237,12,endocrine,O
166237,12,consultation,O
166237,12,did,O
166237,12,not,O
166237,12,feel,O
166237,12,there,O
166237,12,was,O
166237,12,any,O
166237,12,additional,O
166237,12,pathology,O
166237,12,contributing,O
166237,12,to,O
166237,12,the,O
166237,12,elevated,B-ADE
166237,12,gastrin,I-ADE
166237,12,levels,I-ADE
166237,12,.,O
166237,12,-,O
166237,12,[,O
166237,12,**Hospital1,O
166237,12,**,O
166237,12,],O
166237,12,PPI,B-Drug
166237,12,was,O
166237,12,initiated,O
166237,12,and,O
166237,12,should,O
166237,12,be,O
166237,12,continued,O
166237,12,for,O
166237,12,at,O
166237,12,least,O
166237,12,4,O
166237,12,additional,O
166237,12,weeks,O
166237,12,",",O
166237,12,then,O
166237,12,continued,O
166237,12,daily,O
166237,12,.,O
166237,12,-,O
166237,12,Patient,O
166237,12,will,O
166237,13,need,O
166237,13,follow,O
166237,13,up,O
166237,13,with,O
166237,13,gastroenterology,O
166237,13,after,O
166237,13,discharge,O
166237,13,",",O
166237,13,for,O
166237,13,possible,O
166237,13,further,O
166237,13,evaluation,O
166237,13,of,O
166237,13,nodules,O
166237,13,seen,O
166237,13,during,O
166237,13,her,O
166237,13,first,O
166237,13,endoscopy,O
166237,13,.,O
166237,13,.,O
166237,13,#,O
166237,13,C.,B-Reason
166237,13,Difficile,I-Reason
166237,13,Colitis,I-Reason
166237,13,:,O
166237,13,Patient,O
166237,13,developed,O
166237,13,diarrhea,O
166237,13,on,O
166237,13,[,O
166237,13,**2186-11-24**,O
166237,13,],O
166237,13,",",O
166237,13,and,O
166237,13,stool,O
166237,13,samples,O
166237,13,revealed,O
166237,13,c.,B-Reason
166237,13,difficile,I-Reason
166237,13,.,O
166237,13,She,O
166237,13,was,O
166237,13,initiated,O
166237,13,on,O
166237,13,treatment,O
166237,13,with,O
166237,13,flagyl,B-Drug
166237,13,on,O
166237,13,[,O
166237,13,**2186-11-25**,O
166237,13,],O
166237,13,",",O
166237,13,however,O
166237,13,was,O
166237,13,refusing,O
166237,13,oral,O
166237,13,medications,O
166237,13,",",O
166237,13,so,O
166237,13,intravenous,O
166237,13,flagyl,B-Drug
166237,13,was,O
166237,13,administered,O
166237,13,until,O
166237,13,[,O
166237,13,**2186-12-2**,O
166237,13,],O
166237,13,at,O
166237,13,which,O
166237,13,time,O
166237,13,she,O
166237,13,could,O
166237,13,receive,O
166237,13,oral,O
166237,13,medications,O
166237,13,via,O
166237,13,her,O
166237,13,PEG,O
166237,13,.,O
166237,13,She,O
166237,13,did,O
166237,13,not,O
166237,13,have,O
166237,13,any,O
166237,13,abdominal,O
166237,13,pain,O
166237,13,or,O
166237,13,distention,O
166237,13,.,O
166237,13,Her,O
166237,13,white,O
166237,13,blood,O
166237,13,cell,O
166237,13,count,O
166237,13,bumped,O
166237,13,to,O
166237,13,>,O
166237,13,20,O
166237,13,at,O
166237,13,the,O
166237,13,time,O
166237,13,of,O
166237,13,her,B-Reason
166237,13,c.,I-Reason
166237,13,difficile,I-Reason
166237,13,infection,I-Reason
166237,13,.,O
166237,13,Then,O
166237,13,improved,O
166237,13,.,O
166237,13,Around,O
166237,13,[,O
166237,13,**12-5**,O
166237,13,],O
166237,13,her,O
166237,13,WBC,O
166237,13,count,O
166237,13,again,O
166237,13,increased,O
166237,13,",",O
166237,13,with,O
166237,13,no,O
166237,13,other,O
166237,13,clear,O
166237,13,etiology,O
166237,13,found,O
166237,13,.,O
166237,13,It,O
166237,13,was,O
166237,13,decided,O
166237,13,to,O
166237,13,change,O
166237,13,flagyl,B-Drug
166237,13,back,O
166237,13,to,O
166237,13,IV,O
166237,13,",",O
166237,13,and,O
166237,13,to,O
166237,13,add,O
166237,13,PO,O
166237,13,vanco,B-Drug
166237,13,.,O
166237,13,The,O
166237,13,plan,O
166237,13,is,O
166237,13,to,O
166237,13,continue,O
166237,13,IV,O
166237,13,flagyl,B-Drug
166237,13,and,O
166237,13,PO,O
166237,13,vanco,B-Drug
166237,13,until,O
166237,13,about,O
166237,13,a,O
166237,13,week,O
166237,13,after,O
166237,13,WBC,O
166237,13,stopping,O
166237,13,other,O
166237,13,antibiotics,B-Drug
166237,13,(,O
166237,13,cipro,B-Drug
166237,13,for,O
166237,13,UTI,B-Reason
166237,13,),O
166237,13,.,O
166237,13,.,O
166237,13,#,O
166237,13,Bipolar,O
166237,13,Disorder,O
166237,13,:,O
166237,13,Patient,O
166237,13,had,O
166237,13,recent,O
166237,13,hospitalization,O
166237,13,for,O
166237,13,manic,O
166237,13,episode,O
166237,13,at,O
166237,13,outside,O
166237,13,hospital,O
166237,13,.,O
166237,13,She,O
166237,13,has,O
166237,13,long,O
166237,13,standing,O
166237,13,history,O
166237,13,of,O
166237,13,depression,B-Reason
166237,13,and,O
166237,13,manic,B-Reason
166237,13,episodes,I-Reason
166237,13,",",O
166237,13,with,O
166237,13,numerous,O
166237,13,prior,O
166237,13,psychiatric,O
166237,13,admissions,O
166237,13,.,O
166237,13,Her,O
166237,13,family,O
166237,13,gave,O
166237,13,history,O
166237,13,that,O
166237,13,many,O
166237,13,of,O
166237,13,her,O
166237,13,prior,O
166237,13,depressive,O
166237,13,episodes,O
166237,13,had,O
166237,13,started,O
166237,13,with,O
166237,13,refusal,O
166237,13,to,O
166237,13,eat,O
166237,13,.,O
166237,13,.,O
166237,13,Psychiatry,O
166237,13,team,O
166237,13,was,O
166237,13,consulted,O
166237,13,at,O
166237,13,the,O
166237,13,start,O
166237,13,of,O
166237,13,her,O
166237,13,stay,O
166237,13,and,O
166237,13,followed,O
166237,13,along,O
166237,13,the,O
166237,13,entire,O
166237,13,time,O
166237,13,.,O
166237,13,Therapeutic,O
166237,13,options,O
166237,13,for,O
166237,13,her,O
166237,13,bipolar,B-Reason
166237,13,disease,I-Reason
166237,13,were,O
166237,13,limited,O
166237,13,given,O
166237,13,her,O
166237,13,multiple,O
166237,13,serious,O
166237,13,medical,O
166237,13,co-morbidities,O
166237,13,.,O
166237,13,There,O
166237,13,was,O
166237,13,concern,O
166237,13,during,O
166237,13,her,O
166237,13,stay,O
166237,13,for,O
166237,13,seizures,O
166237,13,and,O
166237,13,serotonin,O
166237,13,syndrome,O
166237,13,",",O
166237,13,however,O
166237,13,neither,O
166237,13,was,O
166237,13,felt,O
166237,13,to,O
166237,13,have,O
166237,13,taken,O
166237,13,place,O
166237,13,.,O
166237,13,She,O
166237,13,was,O
166237,13,titrated,O
166237,13,upward,O
166237,13,on,O
166237,13,citalopram,B-Drug
166237,13,to,O
166237,13,40,O
166237,13,mg,O
166237,13,(,O
166237,13,increased,O
166237,13,from,O
166237,13,20,O
166237,13,mg,O
166237,13,on,O
166237,13,[,O
166237,13,**2186-11-24**,O
166237,13,],O
166237,13,and,O
166237,13,increased,O
166237,13,from,O
166237,13,30mg,O
166237,13,on,O
166237,13,[,O
166237,13,**2186-12-11**,O
166237,13,],O
166237,14,),O
166237,14,.,O
166237,14,Given,O
166237,14,her,O
166237,14,prior,O
166237,14,success,O
166237,14,on,O
166237,14,lithium,B-Drug
166237,14,",",O
166237,14,which,O
166237,14,had,O
166237,14,been,O
166237,14,stopped,O
166237,14,due,O
166237,14,to,O
166237,14,``,B-ADE
166237,14,toxicity,I-ADE
166237,14,'',I-ADE
166237,14,of,O
166237,14,unclear,O
166237,14,etiology,O
166237,14,",",O
166237,14,the,O
166237,14,decision,O
166237,14,was,O
166237,14,made,O
166237,14,to,O
166237,14,re-introduce,O
166237,14,lithium,B-Drug
166237,14,while,O
166237,14,in,O
166237,14,the,O
166237,14,inpatient,O
166237,14,setting,O
166237,14,where,O
166237,14,the,O
166237,14,patient,O
166237,14,could,O
166237,14,be,O
166237,14,carefully,O
166237,14,monitored,O
166237,14,.,O
166237,14,150,O
166237,14,mg,O
166237,14,qHS,O
166237,14,was,O
166237,14,started,O
166237,14,on,O
166237,14,[,O
166237,14,**2186-11-8**,O
166237,14,],O
166237,14,",",O
166237,14,and,O
166237,14,levels,O
166237,14,were,O
166237,14,closely,O
166237,14,followed,O
166237,14,",",O
166237,14,with,O
166237,14,goal,O
166237,14,level,O
166237,14,about,O
166237,14,0.5.,O
166237,14,.,O
166237,14,ECT,O
166237,14,:,O
166237,14,Psychiatry,O
166237,14,felt,O
166237,14,that,O
166237,14,one,O
166237,14,of,O
166237,14,the,O
166237,14,best,O
166237,14,options,O
166237,14,would,O
166237,14,be,O
166237,14,ECT,O
166237,14,",",O
166237,14,however,O
166237,14,the,O
166237,14,patient,O
166237,14,continued,O
166237,14,to,O
166237,14,adamantly,O
166237,14,voice,O
166237,14,her,O
166237,14,refusal,O
166237,14,.,O
166237,14,Several,O
166237,14,family,O
166237,14,meetings,O
166237,14,took,O
166237,14,place,O
166237,14,with,O
166237,14,her,O
166237,14,primary,O
166237,14,care,O
166237,14,physician,O
166237,14,",",O
166237,14,[,O
166237,14,**Name10,O
166237,14,(,O
166237,14,NameIs,O
166237,14,),O
166237,14,**,O
166237,14,],O
166237,14,",",O
166237,14,primary,O
166237,14,medical,O
166237,14,",",O
166237,14,and,O
166237,14,psychiatric,O
166237,14,teams,O
166237,14,to,O
166237,14,discuss,O
166237,14,various,O
166237,14,options,O
166237,14,for,O
166237,14,her,O
166237,14,severe,O
166237,14,depression,B-Reason
166237,14,",",O
166237,14,which,O
166237,14,was,O
166237,14,felt,O
166237,14,to,O
166237,14,be,O
166237,14,the,O
166237,14,main,O
166237,14,reason,O
166237,14,for,O
166237,14,her,O
166237,14,failure,O
166237,14,to,O
166237,14,thrive,O
166237,14,and,O
166237,14,poor,O
166237,14,PO,O
166237,14,intake,O
166237,14,.,O
166237,14,Given,O
166237,14,her,O
166237,14,refusal,O
166237,14,to,O
166237,14,ECT,O
166237,14,",",O
166237,14,legal,O
166237,14,guardianship,O
166237,14,would,O
166237,14,need,O
166237,14,to,O
166237,14,be,O
166237,14,pursued,O
166237,14,if,O
166237,14,the,O
166237,14,patient,O
166237,14,'s,O
166237,14,family,O
166237,14,desired,O
166237,14,to,O
166237,14,pursue,O
166237,14,ECT,O
166237,14,and,O
166237,14,it,O
166237,14,was,O
166237,14,necessary,O
166237,14,to,O
166237,14,deem,O
166237,14,the,O
166237,14,patient,O
166237,14,incompetent,O
166237,14,to,O
166237,14,make,O
166237,14,a,O
166237,14,decision,O
166237,14,regarding,O
166237,14,ECT,O
166237,14,due,O
166237,14,to,O
166237,14,her,O
166237,14,depression,B-Reason
166237,14,.,O
166237,14,-,O
166237,14,Remeron,B-Drug
166237,14,was,O
166237,14,considered,O
166237,14,",",O
166237,14,but,O
166237,14,contraindicated,O
166237,14,with,O
166237,14,use,O
166237,14,of,O
166237,14,clonidine,B-Drug
166237,14,.,O
166237,14,-,O
166237,14,Rilatin,B-Drug
166237,14,was,O
166237,14,also,O
166237,14,considered,O
166237,14,",",O
166237,14,but,O
166237,14,contraindicated,O
166237,14,with,O
166237,14,her,O
166237,14,cardiac,O
166237,14,arrhythmias,O
166237,14,.,O
166237,14,-,O
166237,14,Patient,O
166237,14,will,O
166237,14,need,O
166237,14,continued,O
166237,14,follow,O
166237,14,up,O
166237,14,with,O
166237,14,psychiatry,O
166237,14,as,O
166237,14,an,O
166237,14,outpatient,O
166237,14,.,O
166237,14,.,O
166237,14,At,O
166237,14,time,O
166237,14,of,O
166237,14,discharge,O
166237,14,",",O
166237,14,the,O
166237,14,patient,O
166237,14,'s,O
166237,14,mood,O
166237,14,and,O
166237,14,affect,O
166237,14,had,O
166237,14,improved,O
166237,14,greatly,O
166237,14,since,O
166237,14,her,O
166237,14,initial,O
166237,14,presentation,O
166237,14,",",O
166237,14,and,O
166237,14,she,O
166237,14,appeared,O
166237,14,much,O
166237,14,less,O
166237,14,flat,O
166237,14,.,O
166237,14,She,O
166237,14,was,O
166237,14,answering,O
166237,14,questions,O
166237,14,with,O
166237,14,complete,O
166237,14,sentences,O
166237,14,with,O
166237,14,improved,O
166237,14,",",O
166237,14,though,O
166237,14,still,O
166237,14,limited,O
166237,14,",",O
166237,14,range,O
166237,14,of,O
166237,14,emotions,O
166237,14,.,O
166237,14,.,O
166237,14,#,O
166237,14,Failure,O
166237,14,to,O
166237,14,thrive/Anorexia,O
166237,14,-,O
166237,14,Patient,O
166237,14,continued,O
166237,14,to,O
166237,14,refuse,O
166237,14,to,O
166237,14,eat,O
166237,14,and,O
166237,14,take,O
166237,14,her,O
166237,14,medications,O
166237,14,during,O
166237,14,most,O
166237,14,of,O
166237,14,her,O
166237,14,stay,O
166237,14,.,O
166237,14,As,O
166237,14,her,O
166237,14,medical,O
166237,14,problems,O
166237,14,cleared,O
166237,14,",",O
166237,14,she,O
166237,14,became,O
166237,14,more,O
166237,14,interactive,O
166237,14,and,O
166237,14,started,O
166237,14,to,O
166237,15,eat,O
166237,15,small,O
166237,15,amounts,O
166237,15,and,O
166237,15,take,O
166237,15,her,O
166237,15,medications,O
166237,15,.,O
166237,15,After,O
166237,15,much,O
166237,15,discussion,O
166237,15,and,O
166237,15,a,O
166237,15,trial,O
166237,15,of,O
166237,15,one,O
166237,15,week,O
166237,15,once,O
166237,15,medically,O
166237,15,stable,O
166237,15,to,O
166237,15,improve,O
166237,15,PO,O
166237,15,intake,O
166237,15,",",O
166237,15,decision,O
166237,15,was,O
166237,15,made,O
166237,15,to,O
166237,15,place,O
166237,15,PEG,O
166237,15,tube,O
166237,15,",",O
166237,15,which,O
166237,15,was,O
166237,15,completed,O
166237,15,on,O
166237,15,[,O
166237,15,**2186-12-1**,O
166237,15,],O
166237,15,.,O
166237,15,-,O
166237,15,Physical,O
166237,15,therapy,O
166237,15,and,O
166237,15,occupational,O
166237,15,therapy,O
166237,15,were,O
166237,15,consulted,O
166237,15,and,O
166237,15,followed,O
166237,15,along,O
166237,15,during,O
166237,15,the,O
166237,15,patient,O
166237,15,'s,O
166237,15,stay,O
166237,15,.,O
166237,15,-,O
166237,15,Thyroid,O
166237,15,management,O
166237,15,as,O
166237,15,detailed,O
166237,15,above,O
166237,15,.,O
166237,15,.,O
166237,15,#,O
166237,15,Dementia,B-Reason
166237,15,:,O
166237,15,Patient,O
166237,15,has,O
166237,15,history,O
166237,15,of,O
166237,15,mild,O
166237,15,dementia,O
166237,15,.,O
166237,15,She,O
166237,15,was,O
166237,15,initially,O
166237,15,on,O
166237,15,Namenda,B-Drug
166237,15,",",O
166237,15,however,O
166237,15,it,O
166237,15,was,O
166237,15,held,O
166237,15,due,O
166237,15,to,O
166237,15,her,O
166237,15,unresponsive,B-ADE
166237,15,episodes,I-ADE
166237,15,",",O
166237,15,contribution,O
166237,15,to,O
166237,15,hypertension,B-ADE
166237,15,",",O
166237,15,and,O
166237,15,possible,O
166237,15,serotonin,B-ADE
166237,15,syndrome,I-ADE
166237,15,.,O
166237,15,.,O
166237,15,#,O
166237,15,Tachypnea,O
166237,15,:,O
166237,15,Patient,O
166237,15,had,O
166237,15,intermittent,O
166237,15,episodes,O
166237,15,of,O
166237,15,increased,O
166237,15,respiratory,O
166237,15,rate,O
166237,15,",",O
166237,15,ranging,O
166237,15,25,O
166237,15,-,O
166237,15,30,O
166237,15,.,O
166237,15,Her,O
166237,15,oxygenation,O
166237,15,remained,O
166237,15,normal,O
166237,15,",",O
166237,15,and,O
166237,15,her,O
166237,15,lungs,O
166237,15,were,O
166237,15,clear,O
166237,15,",",O
166237,15,and,O
166237,15,she,O
166237,15,denied,O
166237,15,any,O
166237,15,complaints,O
166237,15,.,O
166237,15,Several,O
166237,15,chest,O
166237,15,x-rays,O
166237,15,were,O
166237,15,unrevealing,O
166237,15,.,O
166237,15,Her,O
166237,15,tachypnea,O
166237,15,improved,O
166237,15,overall,O
166237,15,",",O
166237,15,but,O
166237,15,she,O
166237,15,would,O
166237,15,occasionally,O
166237,15,have,O
166237,15,episodes,O
166237,15,of,O
166237,15,increased,O
166237,15,respiratory,O
166237,15,rate,O
166237,15,when,O
166237,15,aroused,O
166237,15,",",O
166237,15,agitated,O
166237,15,(,O
166237,15,eg,O
166237,15,by,O
166237,15,asking,O
166237,15,several,O
166237,15,questions,O
166237,15,),O
166237,15,.,O
166237,15,.,O
166237,15,#,O
166237,15,Acalculus,B-Reason
166237,15,Cholecystitis,I-Reason
166237,15,:,O
166237,15,A,O
166237,15,RUQ,O
166237,15,US,O
166237,15,showed,O
166237,15,possible,O
166237,15,GB,O
166237,15,wall,O
166237,15,necrosis,O
166237,15,and,O
166237,15,microperforation,O
166237,15,.,O
166237,15,Surgery,O
166237,15,was,O
166237,15,consulted,O
166237,15,and,O
166237,15,recommended,O
166237,15,a,O
166237,15,percutaneous,O
166237,15,GB,O
166237,15,tube,O
166237,15,",",O
166237,15,which,O
166237,15,was,O
166237,15,placed,O
166237,15,on,O
166237,15,[,O
166237,15,**2186-10-27**,O
166237,15,],O
166237,15,.,O
166237,15,It,O
166237,15,was,O
166237,15,assumed,O
166237,15,that,O
166237,15,this,O
166237,15,was,O
166237,15,the,O
166237,15,source,O
166237,15,of,O
166237,15,her,O
166237,15,persistent,B-Reason
166237,15,leukocytosis,I-Reason
166237,15,",",O
166237,15,since,O
166237,15,her,O
166237,15,WBC,O
166237,15,fell,O
166237,15,to,O
166237,15,15,O
166237,15,after,O
166237,15,placement,O
166237,15,of,O
166237,15,the,O
166237,15,tube,O
166237,15,",",O
166237,15,but,O
166237,15,the,O
166237,15,WBC,O
166237,15,has,O
166237,15,since,O
166237,15,increased,O
166237,15,.,O
166237,15,On,O
166237,15,[,O
166237,15,**10-28**,O
166237,15,],O
166237,15,after,O
166237,15,the,O
166237,15,procedure,O
166237,15,",",O
166237,15,levo,B-Drug
166237,15,/,O
166237,15,flagyl,B-Drug
166237,15,was,O
166237,15,switched,O
166237,15,to,O
166237,15,zosyn,B-Drug
166237,15,for,O
166237,15,better,O
166237,15,gram,B-Reason
166237,15,negative,I-Reason
166237,15,coverage,I-Reason
166237,15,.,O
166237,15,Vanco,B-Drug
166237,15,was,O
166237,15,continued,O
166237,15,.,O
166237,15,Throughout,O
166237,15,all,O
166237,15,this,O
166237,15,",",O
166237,15,she,O
166237,15,has,O
166237,15,had,O
166237,15,no,O
166237,15,fevers,O
166237,15,",",O
166237,15,denies,O
166237,15,abdominal,O
166237,15,pain,O
166237,15,and,O
166237,15,has,O
166237,15,a,O
166237,15,relatively,O
166237,15,benign,O
166237,15,abd,O
166237,15,exam,O
166237,15,w/,O
166237,15,no,O
166237,15,guarding,O
166237,15,",",O
166237,15,rebound,O
166237,15,or,O
166237,15,RUQ,O
166237,15,tenderness,O
166237,15,.,O
166237,15,Surgery,O
166237,15,strongly,O
166237,15,feels,O
166237,15,that,O
166237,15,she,O
166237,15,does,O
166237,15,not,O
166237,15,have,O
166237,15,an,O
166237,15,``,O
166237,15,acute,O
166237,16,abdmonial,O
166237,16,process,O
166237,16,'',O
166237,16,and,O
166237,16,they,O
166237,16,want,O
166237,16,to,O
166237,16,revisit,O
166237,16,the,O
166237,16,idea,O
166237,16,of,O
166237,16,an,O
166237,16,elective,O
166237,16,cholecystectomy,O
166237,16,in,O
166237,16,[,O
166237,16,**3-18**,O
166237,16,],O
166237,16,weeks,O
166237,16,.,O
166237,16,However,O
166237,16,",",O
166237,16,it,O
166237,16,seems,O
166237,16,most,O
166237,16,likely,O
166237,16,that,O
166237,16,the,O
166237,16,necrotic,O
166237,16,GB,O
166237,16,was,O
166237,16,the,O
166237,16,course,O
166237,16,of,O
166237,16,the,O
166237,16,persistent,O
166237,16,leukocytosis,O
166237,16,.,O
166237,16,-,O
166237,16,Her,O
166237,16,drain,O
166237,16,site,O
166237,16,remained,O
166237,16,clean,O
166237,16,",",O
166237,16,dry,O
166237,16,",",O
166237,16,and,O
166237,16,intact,O
166237,16,.,O
166237,16,-,O
166237,16,Several,O
166237,16,cultures,O
166237,16,from,O
166237,16,her,O
166237,16,bile,O
166237,16,drain,O
166237,16,were,O
166237,16,without,O
166237,16,growth,O
166237,16,except,O
166237,16,for,O
166237,16,one,O
166237,16,that,O
166237,16,haad,O
166237,16,coagulase,O
166237,16,negative,O
166237,16,staph,O
166237,16,",",O
166237,16,felt,O
166237,16,to,O
166237,16,be,O
166237,16,a,O
166237,16,contaminant,O
166237,16,.,O
166237,16,-,O
166237,16,Patient,O
166237,16,'s,O
166237,16,percutaneous,O
166237,16,gall,O
166237,16,bladder,O
166237,16,drain,O
166237,16,was,O
166237,16,clamped,O
166237,16,on,O
166237,16,[,O
166237,16,**12-8**,O
166237,16,],O
166237,16,and,O
166237,16,removed,O
166237,16,on,O
166237,16,[,O
166237,16,**2186-12-11**,O
166237,16,],O
166237,16,.,O
166237,16,.,O
166237,16,#,O
166237,16,Conjunctivitis,B-Reason
166237,16,:,O
166237,16,Patient,O
166237,16,completed,O
166237,16,course,O
166237,16,of,O
166237,16,treatment,O
166237,16,with,O
166237,16,erythromycin,B-Drug
166237,16,eye,O
166237,16,drops,O
166237,16,.,O
166237,16,.,O
166237,16,#,O
166237,16,Oral,O
166237,16,Thrush,O
166237,16,:,O
166237,16,Patient,O
166237,16,occasionally,O
166237,16,had,O
166237,16,evidence,O
166237,16,of,O
166237,16,white,O
166237,16,exudate,O
166237,16,on,O
166237,16,her,O
166237,16,tongue,O
166237,16,",",O
166237,16,which,O
166237,16,was,O
166237,16,possibly,O
166237,16,thrush,O
166237,16,given,O
166237,16,her,O
166237,16,very,O
166237,16,poor,O
166237,16,PO,O
166237,16,intake,O
166237,16,and,O
166237,16,refusal,O
166237,16,of,O
166237,16,mouth,O
166237,16,care,O
166237,16,ans,O
166237,16,swabs,O
166237,16,.,O
166237,16,It,O
166237,16,was,O
166237,16,possible,O
166237,16,that,O
166237,16,thrush,B-Reason
166237,16,was,O
166237,16,also,O
166237,16,contributing,O
166237,16,to,O
166237,16,her,O
166237,16,lack,O
166237,16,of,O
166237,16,appetite,O
166237,16,.,O
166237,16,-,O
166237,16,Nystatin,B-Drug
166237,16,S+S,O
166237,16,was,O
166237,16,initiated,O
166237,16,.,O
166237,16,It,O
166237,16,can,O
166237,16,be,O
166237,16,given,O
166237,16,on,O
166237,16,a,O
166237,16,prn,O
166237,16,basis,O
166237,16,for,O
166237,16,recurrence,O
166237,16,.,O
166237,16,.,O
166237,16,#,O
166237,16,Elevated,O
166237,16,Cardiac,O
166237,16,Enzymes,O
166237,16,:,O
166237,16,Patient,O
166237,16,'s,O
166237,16,cardiac,O
166237,16,enzymes,O
166237,16,bumped,O
166237,16,slightly,O
166237,16,in,O
166237,16,setting,O
166237,16,of,O
166237,16,her,O
166237,16,gastrointestinal,O
166237,16,bleed,O
166237,16,and,O
166237,16,relative,O
166237,16,hypotension,O
166237,16,.,O
166237,16,She,O
166237,16,had,O
166237,16,no,O
166237,16,chest,O
166237,16,pain,O
166237,16,or,O
166237,16,EKG,O
166237,16,changes,O
166237,16,",",O
166237,16,and,O
166237,16,it,O
166237,16,was,O
166237,16,felt,O
166237,16,that,O
166237,16,she,O
166237,16,had,O
166237,16,an,O
166237,16,episode,O
166237,16,of,O
166237,16,demand,O
166237,16,ischemia,O
166237,16,.,O
166237,16,.,O
166237,16,#,O
166237,16,Tranaminitis,O
166237,16,:,O
166237,16,Patient,O
166237,16,'s,O
166237,16,transaminases,O
166237,16,were,O
166237,16,elevated,O
166237,16,into,O
166237,16,the,O
166237,16,[,O
166237,16,**2178**,O
166237,16,],O
166237,16,",",O
166237,16,which,O
166237,16,occurred,O
166237,16,following,O
166237,16,her,O
166237,16,gastrointestinal,O
166237,16,bleed,O
166237,16,and,O
166237,16,episode,O
166237,16,of,O
166237,16,relative,O
166237,16,hypotension,O
166237,16,when,O
166237,16,her,O
166237,16,systolic,O
166237,16,blood,O
166237,16,pressure,O
166237,16,was,O
166237,16,into,O
166237,16,the,O
166237,16,100s,O
166237,16,in,O
166237,16,setting,O
166237,16,of,O
166237,16,bleed,O
166237,16,.,O
166237,16,It,O
166237,16,was,O
166237,16,suspected,O
166237,16,that,O
166237,16,she,O
166237,16,suffered,O
166237,16,from,O
166237,16,ischemic,O
166237,16,process,O
166237,16,(,O
166237,16,CEs,O
166237,16,also,O
166237,16,bumped,O
166237,16,),O
166237,16,due,O
166237,16,to,O
166237,16,hypotension,O
166237,16,.,O
166237,16,She,O
166237,16,had,O
166237,16,also,O
166237,16,been,O
166237,16,getting,O
166237,16,tylenol,B-Drug
166237,16,during,O
166237,16,her,O
166237,16,during,O
166237,16,intensive,O
166237,16,care,O
166237,16,stay,O
166237,16,",",O
166237,16,but,O
166237,16,not,O
166237,16,greater,O
166237,16,than,O
166237,16,2,O
166237,16,grams,O
166237,16,per,O
166237,16,day,O
166237,16,.,O
166237,16,-,O
166237,16,A,O
166237,17,RUQ,O
166237,17,US,O
166237,17,was,O
166237,17,obtained,O
166237,17,to,O
166237,17,rule,O
166237,17,out,O
166237,17,thrombosis,O
166237,17,or,O
166237,17,other,O
166237,17,process,O
166237,17,was,O
166237,17,completed,O
166237,17,without,O
166237,17,any,O
166237,17,apparent,O
166237,17,new,O
166237,17,pathology,O
166237,17,.,O
166237,17,.,O
166237,17,#,O
166237,17,Thrombocytopenia-,O
166237,17,Patient,O
166237,17,developed,O
166237,17,thrombocytopenia,O
166237,17,down,O
166237,17,to,O
166237,17,127,O
166237,17,at,O
166237,17,the,O
166237,17,lowest,O
166237,17,.,O
166237,17,This,O
166237,17,resolved,O
166237,17,during,O
166237,17,her,O
166237,17,stay,O
166237,17,",",O
166237,17,and,O
166237,17,it,O
166237,17,was,O
166237,17,thought,O
166237,17,to,O
166237,17,be,O
166237,17,due,O
166237,17,to,O
166237,17,her,O
166237,17,poor,O
166237,17,nutritional,O
166237,17,status,O
166237,17,.,O
166237,17,-,O
166237,17,There,O
166237,17,were,O
166237,17,no,O
166237,17,clear,O
166237,17,offending,O
166237,17,medications,O
166237,17,on,O
166237,17,her,O
166237,17,medication,O
166237,17,list,O
166237,17,.,O
166237,17,-,O
166237,17,HIT,O
166237,17,testing,O
166237,17,was,O
166237,17,negative,O
166237,17,.,O
166237,17,.,O
166237,17,#,O
166237,17,Leukocytosis,O
166237,17,",",O
166237,17,fevers,O
166237,17,:,O
166237,17,Patient,O
166237,17,had,O
166237,17,fevers,O
166237,17,and,O
166237,17,leukocytosis,O
166237,17,intermittently,O
166237,17,during,O
166237,17,her,O
166237,17,stay,O
166237,17,.,O
166237,17,Patient,O
166237,17,'s,O
166237,17,fevers,O
166237,17,have,O
166237,17,resolved,O
166237,17,",",O
166237,17,but,O
166237,17,she,O
166237,17,has,O
166237,17,had,O
166237,17,continued,O
166237,17,leukocytosis,O
166237,17,.,O
166237,17,Patient,O
166237,17,had,O
166237,17,definite,O
166237,17,spike,O
166237,17,to,O
166237,17,>,O
166237,17,20,O
166237,17,with,O
166237,17,c.,O
166237,17,difficle,O
166237,17,infection,O
166237,17,.,O
166237,17,-,O
166237,17,Patient,O
166237,17,had,O
166237,17,multiple,O
166237,17,sets,O
166237,17,of,O
166237,17,blood,O
166237,17,",",O
166237,17,urine,O
166237,17,",",O
166237,17,stool,O
166237,17,",",O
166237,17,and,O
166237,17,bile,O
166237,17,cultures,O
166237,17,drawn,O
166237,17,;,O
166237,17,her,O
166237,17,chest,O
166237,17,x-ray,O
166237,17,was,O
166237,17,unchanged,O
166237,17,.,O
166237,17,.,O
166237,17,#,O
166237,17,Anemia,O
166237,17,:,O
166237,17,As,O
166237,17,discussed,O
166237,17,above,O
166237,17,in,O
166237,17,regards,O
166237,17,to,O
166237,17,GIB,O
166237,17,.,O
166237,17,Her,O
166237,17,hematocrit,O
166237,17,remained,O
166237,17,stable,O
166237,17,at,O
166237,17,26-28,O
166237,17,range,O
166237,17,prior,O
166237,17,to,O
166237,17,discharge,O
166237,17,.,O
166237,17,Her,O
166237,17,anemia,O
166237,17,was,O
166237,17,that,O
166237,17,of,O
166237,17,chronic,O
166237,17,disease,O
166237,17,as,O
166237,17,well,O
166237,17,as,O
166237,17,losses,O
166237,17,from,O
166237,17,GI,O
166237,17,tract,O
166237,17,.,O
166237,17,.,O
166237,17,#,O
166237,17,Urinary,O
166237,17,retention,O
166237,17,:,O
166237,17,Patient,O
166237,17,had,O
166237,17,several,O
166237,17,voiding,O
166237,17,trials,O
166237,17,with,O
166237,17,removal,O
166237,17,of,O
166237,17,her,O
166237,17,foley,O
166237,17,with,O
166237,17,persistent,O
166237,17,urinary,O
166237,17,retention,O
166237,17,.,O
166237,17,There,O
166237,17,were,O
166237,17,no,O
166237,17,clear,O
166237,17,offending,O
166237,17,medications,O
166237,17,.,O
166237,17,-,O
166237,17,Foley,O
166237,17,replaced,O
166237,17,.,O
166237,17,-,O
166237,17,Patient,O
166237,17,may,O
166237,17,need,O
166237,17,follow,O
166237,17,up,O
166237,17,with,O
166237,17,urology,O
166237,17,to,O
166237,17,further,O
166237,17,management,O
166237,17,of,O
166237,17,her,O
166237,17,foley,O
166237,17,and,O
166237,17,retention,O
166237,17,.,O
166237,17,She,O
166237,17,will,O
166237,17,be,O
166237,17,discharged,O
166237,17,with,O
166237,17,foley,O
166237,17,in,O
166237,17,place,O
166237,17,.,O
166237,17,.,O
166237,17,#,O
166237,17,Tremor,O
166237,17,:,O
166237,17,Patient,O
166237,17,had,O
166237,17,intermittent,O
166237,17,tremor,O
166237,17,of,O
166237,17,her,O
166237,17,left,O
166237,17,arm,O
166237,17,and,O
166237,17,bilateral,O
166237,17,feet,O
166237,17,",",O
166237,17,which,O
166237,17,was,O
166237,17,stable,O
166237,17,.,O
166237,17,It,O
166237,17,was,O
166237,17,not,O
166237,17,present,O
166237,17,except,O
166237,17,when,O
166237,17,asked,O
166237,17,several,O
166237,17,questions,O
166237,17,and,O
166237,17,stimulated,O
166237,17,.,O
166237,17,Does,O
166237,17,not,O
166237,17,cause,O
166237,17,patient,O
166237,17,any,O
166237,17,distress,O
166237,17,.,O
166237,17,Tremor,O
166237,17,only,O
166237,17,present,O
166237,17,when,O
166237,17,patient,O
166237,17,stimulated,O
166237,17,or,O
166237,17,agitated,O
166237,17,",",O
166237,17,not,O
166237,17,present,O
166237,17,in,O
166237,17,sleep,O
166237,17,or,O
166237,17,when,O
166237,17,calm,O
166237,17,.,O
166237,17,No,O
166237,17,other,O
166237,17,evidence,O
166237,17,of,O
166237,17,toxicity,O
166237,17,or,O
166237,17,increased,O
166237,17,tone,O
166237,17,.,O
166237,17,.,O
166237,17,Medications,O
166237,17,on,O
166237,17,Admission,O
166237,17,:,O
166237,17,Home,O
166237,17,Medications,O
166237,18,:,O
166237,18,risperdal,B-Drug
166237,18,2,O
166237,18,mg,O
166237,18,qhs,O
166237,18,trazodone,B-Drug
166237,18,25,O
166237,18,mg,O
166237,18,qhs,O
166237,18,Atorvastatin,B-Drug
166237,18,10,O
166237,18,mg,O
166237,18,PO,O
166237,18,HS,O
166237,18,CloniDINE,B-Drug
166237,18,0.3,O
166237,18,mg,O
166237,18,PO,O
166237,18,BID,O
166237,18,Diltiazem,B-Drug
166237,18,Extended-Release,I-Drug
166237,18,120,O
166237,18,mg,O
166237,18,PO,O
166237,18,DAILY,O
166237,18,GlipiZIDE,B-Drug
166237,18,2.5,O
166237,18,mg,O
166237,18,PO,O
166237,18,DAILY,O
166237,18,Hydrochlorothiazide,B-Drug
166237,18,25,O
166237,18,mg,O
166237,18,PO,O
166237,18,DAILY,O
166237,18,Isosorbide,B-Drug
166237,18,Mononitrate,I-Drug
166237,18,(,I-Drug
166237,18,Extended,I-Drug
166237,18,Release,I-Drug
166237,18,),I-Drug
166237,18,30,O
166237,18,mg,O
166237,18,PO,O
166237,18,DAILY,O
166237,18,Metoprolol,B-Drug
166237,18,XL,I-Drug
166237,18,(,I-Drug
166237,18,Toprol,I-Drug
166237,18,XL,I-Drug
166237,18,),I-Drug
166237,18,200,O
166237,18,mg,O
166237,18,PO,O
166237,18,DAILY,O
166237,18,Sertraline,B-Drug
166237,18,50,O
166237,18,mg,O
166237,18,PO,O
166237,18,DAILY,O
166237,18,Levothyroxine,B-Drug
166237,18,Sodium,I-Drug
166237,18,150,O
166237,18,mcg,O
166237,18,PO,O
166237,18,DAILY,O
166237,18,.,O
166237,18,Medications,O
166237,18,(,O
166237,18,on,O
166237,18,transfer,O
166237,18,),O
166237,18,:,O
166237,18,Atorvastatin,B-Drug
166237,18,10,O
166237,18,mg,O
166237,18,PO,O
166237,18,HS,O
166237,18,CloniDINE,B-Drug
166237,18,0.3,O
166237,18,mg,O
166237,18,PO,O
166237,18,BID,O
166237,18,Namenda,B-Drug
166237,18,*NF*,I-Drug
166237,18,5,O
166237,18,mg,O
166237,18,Oral,O
166237,18,[,O
166237,18,**Hospital1,O
166237,18,**,O
166237,18,],O
166237,18,Levothyroxine,B-Drug
166237,18,Sodium,I-Drug
166237,18,150,O
166237,18,mcg,O
166237,18,PO,O
166237,18,DAILY,O
166237,18,Metoprolol,B-Drug
166237,18,XL,I-Drug
166237,18,(,I-Drug
166237,18,Toprol,I-Drug
166237,18,XL,I-Drug
166237,18,),I-Drug
166237,18,200,O
166237,18,mg,O
166237,18,PO,O
166237,18,DAILY,O
166237,18,Isosorbide,B-Drug
166237,18,Mononitrate,I-Drug
166237,18,(,I-Drug
166237,18,Extended,I-Drug
166237,18,Release,I-Drug
166237,18,),I-Drug
166237,18,30,O
166237,18,mg,O
166237,18,PO,O
166237,18,DAILY,O
166237,18,Diltiazem,B-Drug
166237,18,Extended-Release,I-Drug
166237,18,120,O
166237,18,mg,O
166237,18,PO,O
166237,18,DAILY,O
166237,18,Docusate,B-Drug
166237,18,Sodium,I-Drug
166237,18,100,O
166237,18,mg,O
166237,18,PO,O
166237,18,BID,O
166237,18,GlipiZIDE,B-Drug
166237,18,2.5,O
166237,18,mg,O
166237,18,PO,O
166237,18,DAILY,O
166237,18,Heparin,B-Drug
166237,18,5000,O
166237,18,UNIT,O
166237,18,SC,O
166237,18,TID,O
166237,18,Hydrochlorothiazide,B-Drug
166237,18,25,O
166237,18,mg,O
166237,18,PO,O
166237,18,DAILY,O
166237,18,traZODONE,B-Drug
166237,18,25,O
166237,18,mg,O
166237,18,PO,O
166237,18,HS,O
166237,18,Senna,B-Drug
166237,18,2,O
166237,18,TAB,O
166237,18,PO,O
166237,18,DAILY,O
166237,18,Sertraline,B-Drug
166237,18,50,O
166237,18,mg,O
166237,18,PO,O
166237,18,DAILY,O
166237,18,Risperidone,B-Drug
166237,18,2,O
166237,18,mg,O
166237,18,PO,O
166237,18,HS,O
166237,18,.,O
166237,18,Allergies,O
166237,18,:,O
166237,18,Wellbutrin,B-Drug
166237,18,-,O
166237,18,nausea,B-ADE
166237,18,and,O
166237,18,vomiting,B-ADE
166237,18,Kaopectate,O
166237,18,-,O
166237,18,loss,B-ADE
166237,18,of,I-ADE
166237,18,balance,I-ADE
166237,18,and,O
166237,18,alopecia,B-ADE
166237,18,Discharge,O
166237,18,Medications,O
166237,18,:,O
166237,18,1,O
166237,18,.,O
166237,18,Levothyroxine,B-Drug
166237,18,175,O
166237,18,mcg,O
166237,18,Tablet,O
166237,18,[,O
166237,18,**Hospital1,O
166237,18,**,O
166237,18,],O
166237,18,:,O
166237,18,One,O
166237,18,(,O
166237,18,1,O
166237,18,),O
166237,18,Tablet,O
166237,18,PO,O
166237,18,DAILY,O
166237,18,(,O
166237,18,Daily,O
166237,18,),O
166237,18,:,O
166237,18,hold,O
166237,18,tube,O
166237,18,feeds,O
166237,18,30,O
166237,18,minutes,O
166237,18,before,O
166237,18,and,O
166237,18,30,O
166237,18,minutes,O
166237,18,after,O
166237,18,administration,O
166237,18,.,O
166237,18,Do,O
166237,18,not,O
166237,18,given,O
166237,18,within,O
166237,18,30,O
166237,18,minutes,O
166237,18,of,O
166237,18,any,O
166237,18,other,O
166237,18,medication,O
166237,18,.,O
166237,18,2,O
166237,18,.,O
166237,18,Docusate,B-Drug
166237,18,Sodium,I-Drug
166237,18,50,O
166237,18,mg/5,O
166237,18,mL,O
166237,18,Liquid,O
166237,18,[,O
166237,18,**Hospital1,O
166237,18,**,O
166237,18,],O
166237,18,:,O
166237,18,One,O
166237,18,(,O
166237,18,1,O
166237,18,),O
166237,18,PO,O
166237,18,BID,O
166237,18,(,O
166237,18,2,O
166237,18,times,O
166237,18,a,O
166237,18,day,O
166237,18,),O
166237,18,.,O
166237,18,3,O
166237,18,.,O
166237,18,Atorvastatin,B-Drug
166237,18,10,O
166237,18,mg,O
166237,18,Tablet,O
166237,18,[,O
166237,18,**Hospital1,O
166237,18,**,O
166237,18,],O
166237,18,:,O
166237,18,One,O
166237,18,(,O
166237,18,1,O
166237,18,),O
166237,18,Tablet,O
166237,18,PO,O
166237,18,HS,O
166237,18,(,O
166237,18,at,O
166237,18,bedtime,O
166237,18,),O
166237,18,.,O
166237,18,4,O
166237,18,.,O
166237,18,Senna,B-Drug
166237,18,8.6,O
166237,18,mg,O
166237,18,Tablet,O
166237,18,[,O
166237,18,**Hospital1,O
166237,18,**,O
166237,18,],O
166237,18,:,O
166237,18,Two,O
166237,18,(,O
166237,18,2,O
166237,18,),O
166237,18,Tablet,O
166237,18,PO,O
166237,18,DAILY,O
166237,18,(,O
166237,18,Daily,O
166237,18,),O
166237,18,.,O
166237,18,5,O
166237,19,.,O
166237,19,Polyvinyl,B-Drug
166237,19,Alcohol-Povidone,I-Drug
166237,19,1.4-0.6,O
166237,19,%,O
166237,19,Dropperette,O
166237,19,[,O
166237,19,**Hospital1,O
166237,19,**,O
166237,19,],O
166237,19,:,O
166237,19,[,O
166237,19,**12-13**,O
166237,19,],O
166237,19,Drops,O
166237,19,Ophthalmic,O
166237,19,PRN,O
166237,19,(,O
166237,19,as,O
166237,19,needed,O
166237,19,),O
166237,19,.,O
166237,19,6,O
166237,19,.,O
166237,19,Lithium,B-Drug
166237,19,Carbonate,I-Drug
166237,19,150,O
166237,19,mg,O
166237,19,Capsule,O
166237,19,[,O
166237,19,**Month/Day,O
166237,19,(,O
166237,19,2,O
166237,19,),O
166237,19,**,O
166237,19,],O
166237,19,:,O
166237,19,One,O
166237,19,(,O
166237,19,1,O
166237,19,),O
166237,19,Capsule,O
166237,19,PO,O
166237,19,QHS,O
166237,19,(,O
166237,19,once,O
166237,19,a,O
166237,19,day,O
166237,19,(,O
166237,19,at,O
166237,19,bedtime,O
166237,19,),O
166237,19,),O
166237,19,.,O
166237,19,7,O
166237,19,.,O
166237,19,Amiodarone,B-Drug
166237,19,200,O
166237,19,mg,O
166237,19,Tablet,O
166237,19,[,O
166237,19,**Month/Day,O
166237,19,(,O
166237,19,2,O
166237,19,),O
166237,19,**,O
166237,19,],O
166237,19,:,O
166237,19,One,O
166237,19,(,O
166237,19,1,O
166237,19,),O
166237,19,Tablet,O
166237,19,PO,O
166237,19,DAILY,O
166237,19,(,O
166237,19,Daily,O
166237,19,),O
166237,19,.,O
166237,19,8,O
166237,19,.,O
166237,19,Calcium,B-Drug
166237,19,Carbonate,I-Drug
166237,19,500,O
166237,19,mg,O
166237,19,Tablet,O
166237,19,",",O
166237,19,Chewable,O
166237,19,[,O
166237,19,**Month/Day,O
166237,19,(,O
166237,19,2,O
166237,19,),O
166237,19,**,O
166237,19,],O
166237,19,:,O
166237,19,One,O
166237,19,(,O
166237,19,1,O
166237,19,),O
166237,19,Tablet,O
166237,19,",",O
166237,19,Chewable,O
166237,19,PO,O
166237,19,TID,O
166237,19,(,O
166237,19,3,O
166237,19,times,O
166237,19,a,O
166237,19,day,O
166237,19,),O
166237,19,.,O
166237,19,9,O
166237,19,.,O
166237,19,Sucralfate,B-Drug
166237,19,1,O
166237,19,gram,O
166237,19,Tablet,O
166237,19,[,O
166237,19,**Month/Day,O
166237,19,(,O
166237,19,2,O
166237,19,),O
166237,19,**,O
166237,19,],O
166237,19,:,O
166237,19,One,O
166237,19,(,O
166237,19,1,O
166237,19,),O
166237,19,Tablet,O
166237,19,PO,O
166237,19,QID,O
166237,19,(,O
166237,19,4,O
166237,19,times,O
166237,19,a,O
166237,19,day,O
166237,19,),O
166237,19,.,O
166237,19,10,O
166237,19,.,O
166237,19,Lansoprazole,B-Drug
166237,19,30,O
166237,19,mg,O
166237,19,Tablet,O
166237,19,",",O
166237,19,Rapid,O
166237,19,Dissolve,O
166237,19,",",O
166237,19,DR,O
166237,19,[,O
166237,19,**Last,O
166237,19,Name,O
166237,19,(,O
166237,19,STitle,O
166237,19,),O
166237,19,**,O
166237,19,],O
166237,19,:,O
166237,19,One,O
166237,19,(,O
166237,19,1,O
166237,19,),O
166237,19,Tablet,O
166237,19,",",O
166237,19,Rapid,O
166237,19,Dissolve,O
166237,19,",",O
166237,19,DR,O
166237,19,PO,O
166237,19,BID,O
166237,19,(,O
166237,19,2,O
166237,19,times,O
166237,19,a,O
166237,19,day,O
166237,19,),O
166237,19,.,O
166237,19,11,O
166237,19,.,O
166237,19,Clonidine,B-Drug
166237,19,0.2,O
166237,19,mg/24,O
166237,19,hr,O
166237,19,Patch,O
166237,19,Weekly,O
166237,19,[,O
166237,19,**Last,O
166237,19,Name,O
166237,19,(,O
166237,19,STitle,O
166237,19,),O
166237,19,**,O
166237,19,],O
166237,19,:,O
166237,19,One,O
166237,19,(,O
166237,19,1,O
166237,19,),O
166237,19,Patch,O
166237,19,Weekly,O
166237,19,Transdermal,O
166237,19,QTHUR,O
166237,19,(,O
166237,19,every,O
166237,19,Thursday,O
166237,19,),O
166237,19,.,O
166237,19,12,O
166237,19,.,O
166237,19,Citalopram,B-Drug
166237,19,40,O
166237,19,mg,O
166237,19,Tablet,O
166237,19,[,O
166237,19,**Last,O
166237,19,Name,O
166237,19,(,O
166237,19,STitle,O
166237,19,),O
166237,19,**,O
166237,19,],O
166237,19,:,O
166237,19,One,O
166237,19,(,O
166237,19,1,O
166237,19,),O
166237,19,Tablet,O
166237,19,PO,O
166237,19,once,O
166237,19,a,O
166237,19,day,O
166237,19,.,O
166237,19,13,O
166237,19,.,O
166237,19,Captopril,B-Drug
166237,19,25,O
166237,19,mg,O
166237,19,Tablet,O
166237,19,[,O
166237,19,**Last,O
166237,19,Name,O
166237,19,(,O
166237,19,STitle,O
166237,19,),O
166237,19,**,O
166237,19,],O
166237,19,:,O
166237,19,Three,O
166237,19,(,O
166237,19,3,O
166237,19,),O
166237,19,Tablet,O
166237,19,PO,O
166237,19,Q8H,O
166237,19,(,O
166237,19,every,O
166237,19,8,O
166237,19,hours,O
166237,19,),O
166237,19,.,O
166237,19,14,O
166237,19,.,O
166237,19,Metoprolol,B-Drug
166237,19,Tartrate,I-Drug
166237,19,50,O
166237,19,mg,O
166237,19,Tablet,O
166237,19,[,O
166237,19,**Last,O
166237,19,Name,O
166237,19,(,O
166237,19,STitle,O
166237,19,),O
166237,19,**,O
166237,19,],O
166237,19,:,O
166237,19,Two,O
166237,19,(,O
166237,19,2,O
166237,19,),O
166237,19,Tablet,O
166237,19,PO,O
166237,19,Q8H,O
166237,19,(,O
166237,19,every,O
166237,19,8,O
166237,19,hours,O
166237,19,),O
166237,19,.,O
166237,19,15,O
166237,19,.,O
166237,19,Bisacodyl,B-Drug
166237,19,5,O
166237,19,mg,O
166237,19,Tablet,O
166237,19,",",O
166237,19,Delayed,O
166237,19,Release,O
166237,20,(,O
166237,20,E.C,O
166237,20,.,O
166237,20,),O
166237,20,[,O
166237,20,**Last,O
166237,20,Name,O
166237,20,(,O
166237,20,STitle,O
166237,20,),O
166237,20,**,O
166237,20,],O
166237,20,:,O
166237,20,Two,O
166237,20,(,O
166237,20,2,O
166237,20,),O
166237,20,Tablet,O
166237,20,",",O
166237,20,Delayed,O
166237,20,Release,O
166237,20,(,O
166237,20,E.C,O
166237,20,.,O
166237,20,),O
166237,20,PO,O
166237,20,DAILY,O
166237,20,(,O
166237,20,Daily,O
166237,20,),O
166237,20,as,O
166237,20,needed,O
166237,20,for,O
166237,20,constipation,B-Reason
166237,20,.,O
166237,20,Tablet,O
166237,20,",",O
166237,20,Delayed,O
166237,20,Release,O
166237,20,(,O
166237,20,E.C,O
166237,20,.,O
166237,20,),O
166237,20,(,O
166237,20,s,O
166237,20,),O
166237,20,16,O
166237,20,.,O
166237,20,Nystatin,B-Drug
166237,20,"100,000",O
166237,20,unit/mL,O
166237,20,Suspension,O
166237,20,[,O
166237,20,**Last,O
166237,20,Name,O
166237,20,(,O
166237,20,STitle,O
166237,20,),O
166237,20,**,O
166237,20,],O
166237,20,:,O
166237,20,Five,O
166237,20,(,O
166237,20,5,O
166237,20,),O
166237,20,ML,O
166237,20,PO,O
166237,20,QID,O
166237,20,(,O
166237,20,4,O
166237,20,times,O
166237,20,a,O
166237,20,day,O
166237,20,),O
166237,20,as,O
166237,20,needed,O
166237,20,for,O
166237,20,thrush,B-Reason
166237,20,.,O
166237,20,17,O
166237,20,.,O
166237,20,Miconazole,B-Drug
166237,20,Nitrate,I-Drug
166237,20,2,O
166237,20,%,O
166237,20,Powder,O
166237,20,[,O
166237,20,**Last,O
166237,20,Name,O
166237,20,(,O
166237,20,STitle,O
166237,20,),O
166237,20,**,O
166237,20,],O
166237,20,:,O
166237,20,One,O
166237,20,(,O
166237,20,1,O
166237,20,),O
166237,20,Appl,O
166237,20,Topical,O
166237,20,TID,O
166237,20,(,O
166237,20,3,O
166237,20,times,O
166237,20,a,O
166237,20,day,O
166237,20,),O
166237,20,as,O
166237,20,needed,O
166237,20,for,O
166237,20,rash,B-Reason
166237,20,.,O
166237,20,18,O
166237,20,.,O
166237,20,Sodium,B-Drug
166237,20,Chloride,I-Drug
166237,20,0.65,O
166237,20,%,O
166237,20,Aerosol,O
166237,20,",",O
166237,20,Spray,O
166237,20,[,O
166237,20,**Last,O
166237,20,Name,O
166237,20,(,O
166237,20,STitle,O
166237,20,),O
166237,20,**,O
166237,20,],O
166237,20,:,O
166237,20,[,O
166237,20,**12-13**,O
166237,20,],O
166237,20,Sprays,O
166237,20,Nasal,O
166237,20,QID,O
166237,20,(,O
166237,20,4,O
166237,20,times,O
166237,20,a,O
166237,20,day,O
166237,20,),O
166237,20,as,O
166237,20,needed,O
166237,20,.,O
166237,20,19,O
166237,20,.,O
166237,20,Heparin,B-Drug
166237,20,(,I-Drug
166237,20,Porcine,I-Drug
166237,20,),I-Drug
166237,20,"5,000",O
166237,20,unit/mL,O
166237,20,Solution,O
166237,20,[,O
166237,20,**Month/Day,O
166237,20,(,O
166237,20,2,O
166237,20,),O
166237,20,**,O
166237,20,],O
166237,20,:,O
166237,20,One,O
166237,20,(,O
166237,20,1,O
166237,20,),O
166237,20,Injection,O
166237,20,TID,O
166237,20,(,O
166237,20,3,O
166237,20,times,O
166237,20,a,O
166237,20,day,O
166237,20,),O
166237,20,.,O
166237,20,20,O
166237,20,.,O
166237,20,Vancomycin,B-Drug
166237,20,250,O
166237,20,mg,O
166237,20,Capsule,O
166237,20,[,O
166237,20,**Month/Day,O
166237,20,(,O
166237,20,2,O
166237,20,),O
166237,20,**,O
166237,20,],O
166237,20,:,O
166237,20,One,O
166237,20,(,O
166237,20,1,O
166237,20,),O
166237,20,Capsule,O
166237,20,PO,O
166237,20,Q6H,O
166237,20,(,O
166237,20,every,O
166237,20,6,O
166237,20,hours,O
166237,20,),O
166237,20,for,O
166237,20,5,O
166237,20,days,O
166237,20,.,O
166237,20,21,O
166237,20,.,O
166237,20,Insulin,B-Drug
166237,20,Insulin,O
166237,20,therapy,O
166237,20,as,O
166237,20,per,O
166237,20,sliding,O
166237,20,scale,O
166237,20,22,O
166237,20,.,O
166237,20,Outpatient,O
166237,20,Lab,O
166237,20,Work,O
166237,20,TSH,O
166237,20,",",O
166237,20,free,O
166237,20,T4,O
166237,20,to,O
166237,20,be,O
166237,20,checked,O
166237,20,on,O
166237,20,or,O
166237,20,around,O
166237,20,[,O
166237,20,**2186-12-26**,O
166237,20,],O
166237,20,.,O
166237,20,To,O
166237,20,be,O
166237,20,followed,O
166237,20,by,O
166237,20,[,O
166237,20,**Location,O
166237,20,(,O
166237,20,un,O
166237,20,),O
166237,20,583**,O
166237,20,],O
166237,20,House,O
166237,20,and/or,O
166237,20,Dr.,O
166237,20,[,O
166237,20,**Last,O
166237,20,Name,O
166237,20,(,O
166237,20,STitle,O
166237,20,),O
166237,20,1266**,O
166237,20,],O
166237,20,.,O
166237,20,23,O
166237,20,.,O
166237,20,Outpatient,O
166237,20,Lab,O
166237,20,Work,O
166237,20,CBC,O
166237,20,",",O
166237,20,chem,O
166237,20,7,O
166237,20,to,O
166237,20,be,O
166237,20,checked,O
166237,20,on,O
166237,20,or,O
166237,20,around,O
166237,20,[,O
166237,20,**2186-12-22**,O
166237,20,],O
166237,20,;,O
166237,20,to,O
166237,20,be,O
166237,20,followed,O
166237,20,by,O
166237,20,[,O
166237,20,**Location,O
166237,20,(,O
166237,20,un,O
166237,20,),O
166237,20,583**,O
166237,20,],O
166237,20,House,O
166237,20,and/or,O
166237,20,Dr.,O
166237,20,[,O
166237,20,**Last,O
166237,20,Name,O
166237,20,(,O
166237,20,STitle,O
166237,20,),O
166237,20,1266**,O
166237,20,],O
166237,20,.,O
166237,20,Discharge,O
166237,21,Disposition,O
166237,21,:,O
166237,21,Extended,O
166237,21,Care,O
166237,21,Facility,O
166237,21,:,O
166237,21,[,O
166237,21,**Location,O
166237,21,(,O
166237,21,un,O
166237,21,),O
166237,21,583**,O
166237,21,],O
166237,21,House,O
166237,21,Discharge,O
166237,21,Diagnosis,O
166237,21,:,O
166237,21,Primary,O
166237,21,Diagnosis,O
166237,21,:,O
166237,21,depression,O
166237,21,new,O
166237,21,mulifocial,O
166237,21,atrial,O
166237,21,tachycardia,O
166237,21,",",O
166237,21,ventricular,O
166237,21,tachycardia,O
166237,21,on,O
166237,21,EKG,O
166237,21,Secondary,O
166237,21,Diagnosis,O
166237,21,:,O
166237,21,failure,O
166237,21,to,O
166237,21,thrive,O
166237,21,labile,O
166237,21,hypertension,O
166237,21,poorly,O
166237,21,controlled,O
166237,21,diabetes,O
166237,21,mellitus,O
166237,21,Discharge,O
166237,21,Condition,O
166237,21,:,O
166237,21,improved,O
166237,21,.,O
166237,21,Discharge,O
166237,21,Instructions,O
166237,21,:,O
166237,21,You,O
166237,21,were,O
166237,21,admitted,O
166237,21,to,O
166237,21,the,O
166237,21,hosptial,O
166237,21,for,O
166237,21,depression,O
166237,21,and,O
166237,21,failure,O
166237,21,to,O
166237,21,thrive,O
166237,21,.,O
166237,21,For,O
166237,21,your,O
166237,21,depression,B-Reason
166237,21,and,O
166237,21,failure,B-Reason
166237,21,to,I-Reason
166237,21,thrive,I-Reason
166237,21,",",O
166237,21,you,O
166237,21,were,O
166237,21,evaluated,O
166237,21,by,O
166237,21,our,O
166237,21,psychiatrists,O
166237,21,who,O
166237,21,started,O
166237,21,you,O
166237,21,on,O
166237,21,two,O
166237,21,new,O
166237,21,medications,O
166237,21,called,O
166237,21,celexa,B-Drug
166237,21,and,O
166237,21,lithium,B-Drug
166237,21,.,O
166237,21,These,O
166237,21,medications,O
166237,21,seemed,O
166237,21,to,O
166237,21,help,O
166237,21,your,O
166237,21,mood,O
166237,21,and,O
166237,21,improved,O
166237,21,your,O
166237,21,communication,O
166237,21,.,O
166237,21,While,O
166237,21,you,O
166237,21,were,O
166237,21,here,O
166237,21,",",O
166237,21,you,O
166237,21,also,O
166237,21,had,O
166237,21,several,O
166237,21,other,O
166237,21,medical,O
166237,21,problems,O
166237,21,including,O
166237,21,labile,O
166237,21,hypertension,O
166237,21,",",O
166237,21,uncontrolled,O
166237,21,blood,O
166237,21,sugars,O
166237,21,",",O
166237,21,gastrointestinal,O
166237,21,bleeding,O
166237,21,",",O
166237,21,episodes,O
166237,21,of,O
166237,21,unresponsiveness,O
166237,21,",",O
166237,21,and,O
166237,21,infection,O
166237,21,of,O
166237,21,your,O
166237,21,gall,O
166237,21,bladder,O
166237,21,.,O
166237,21,.,O
166237,21,Your,O
166237,21,blood,O
166237,21,pressure,O
166237,21,and,O
166237,21,blood,O
166237,21,sugars,O
166237,21,were,O
166237,21,controlled,O
166237,21,.,O
166237,21,You,O
166237,21,were,O
166237,21,given,O
166237,21,nutrition,B-Drug
166237,21,via,O
166237,21,intravenous,O
166237,21,administration,O
166237,21,and,O
166237,21,via,O
166237,21,a,O
166237,21,tube,O
166237,21,going,O
166237,21,from,O
166237,21,your,O
166237,21,nose,O
166237,21,to,O
166237,21,your,O
166237,21,stomach,O
166237,21,.,O
166237,21,You,O
166237,21,were,O
166237,21,also,O
166237,21,found,O
166237,21,to,O
166237,21,have,O
166237,21,a,O
166237,21,new,O
166237,21,heart,O
166237,21,arrythmia,O
166237,21,and,O
166237,21,transient,O
166237,21,renal,O
166237,21,failure,O
166237,21,.,O
166237,21,You,O
166237,21,were,O
166237,21,seen,O
166237,21,by,O
166237,21,psychiatry,O
166237,21,and,O
166237,21,treated,O
166237,21,daily,O
166237,21,for,O
166237,21,your,O
166237,21,depression,O
166237,21,as,O
166237,21,we,O
166237,21,stabilized,O
166237,21,you,O
166237,21,medically,O
166237,21,.,O
166237,21,.,O
166237,21,You,O
166237,21,also,O
166237,21,developed,O
166237,21,a,O
166237,21,bleed,B-Reason
166237,21,from,I-Reason
166237,21,your,I-Reason
166237,21,gastrointestinal,I-Reason
166237,21,tract,I-Reason
166237,21,",",O
166237,21,and,O
166237,21,required,O
166237,21,blood,B-Drug
166237,21,transfusions,O
166237,21,.,O
166237,21,.,O
166237,21,The,O
166237,21,medicines,O
166237,21,we,O
166237,21,stopped,O
166237,21,were,O
166237,21,:,O
166237,21,risperdal,B-Drug
166237,21,",",O
166237,21,trazodone,B-Drug
166237,21,",",O
166237,21,diltiazem,B-Drug
166237,21,",",O
166237,21,glipizide,B-Drug
166237,21,",",O
166237,21,HCTZ,B-Drug
166237,21,",",O
166237,21,Imdur,B-Drug
166237,21,",",O
166237,21,sertraline,B-Drug
166237,21,.,O
166237,21,The,O
166237,21,medicines,O
166237,21,we,O
166237,21,started,O
166237,21,were,O
166237,21,:,O
166237,21,amiodarone,B-Drug
166237,21,",",O
166237,21,lansoprazole,B-Drug
166237,21,",",O
166237,21,insulin,B-Drug
166237,21,",",O
166237,21,captopril,B-Drug
166237,21,",",O
166237,21,citalopram,B-Drug
166237,21,",",O
166237,21,calcium,B-Drug
166237,21,",",O
166237,21,colace,B-Drug
166237,21,",",O
166237,21,sucralfate,B-Drug
166237,21,",",O
166237,21,senna,B-Drug
166237,21,",",O
166237,21,lithium,B-Drug
166237,21,",",O
166237,21,vancomycin,B-Drug
166237,21,oral,O
166237,21,liquid,O
166237,21,(,O
166237,21,thru,O
166237,21,[,O
166237,21,**12-23**,O
166237,21,],O
166237,21,),O
166237,21,.,O
166237,21,The,O
166237,21,medications,O
166237,21,we,O
166237,21,changed,O
166237,21,were,O
166237,21,:,O
166237,21,clonidine,B-Drug
166237,21,(,O
166237,21,now,O
166237,21,taking,O
166237,21,as,O
166237,21,a,O
166237,21,patch,O
166237,21,),O
166237,21,",",O
166237,21,levothyroxine,B-Drug
166237,21,(,O
166237,21,increased,O
166237,21,to,O
166237,21,175,O
166237,21,mcg,O
166237,21,per,O
166237,21,day,O
166237,21,),O
166237,21,",",O
166237,21,metoprolol,B-Drug
166237,21,(,O
166237,21,increased,O
166237,21,to,O
166237,21,300,O
166237,21,per,O
166237,22,day,O
166237,22,),O
166237,22,.,O
166237,22,Please,O
166237,22,take,O
166237,22,all,O
166237,22,of,O
166237,22,your,O
166237,22,medications,O
166237,22,as,O
166237,22,directed,O
166237,22,.,O
166237,22,Followup,O
166237,22,Instructions,O
166237,22,:,O
166237,22,Please,O
166237,22,continue,O
166237,22,your,O
166237,22,stay,O
166237,22,at,O
166237,22,the,O
166237,22,rehabilitation,O
166237,22,facility,O
166237,22,until,O
166237,22,you,O
166237,22,are,O
166237,22,deemed,O
166237,22,ready,O
166237,22,to,O
166237,22,leave,O
166237,22,.,O
166237,22,Please,O
166237,22,follow-up,O
166237,22,closely,O
166237,22,with,O
166237,22,an,O
166237,22,outside,O
166237,22,hosptial,O
166237,22,psychiatrist,O
166237,22,.,O
166237,22,.,O
166237,22,Once,O
166237,22,you,O
166237,22,are,O
166237,22,discharged,O
166237,22,from,O
166237,22,you,O
166237,22,rehabilitation,O
166237,22,facility,O
166237,22,please,O
166237,22,follow-up,O
166237,22,with,O
166237,22,a,O
166237,22,cardiologist,O
166237,22,of,O
166237,22,your,O
166237,22,choice,O
166237,22,to,O
166237,22,address,O
166237,22,your,O
166237,22,new,O
166237,22,heart,O
166237,22,arrhythmia,O
166237,22,.,O
166237,22,.,O
166237,22,Please,O
166237,22,call,O
166237,22,your,O
166237,22,primary,O
166237,22,care,O
166237,22,physician,O
166237,22,",",O
166237,22,[,O
166237,22,**Last,O
166237,22,Name,O
166237,22,(,O
166237,22,NamePattern4,O
166237,22,),O
166237,22,**,O
166237,22,],O
166237,22,.,O
166237,22,[,O
166237,22,**Last,O
166237,22,Name,O
166237,22,(,O
166237,22,STitle,O
166237,22,),O
166237,22,1266**,O
166237,22,],O
166237,22,",",O
166237,22,[,O
166237,22,**Telephone/Fax,O
166237,22,(,O
166237,22,1,O
166237,22,),O
166237,22,608**,O
166237,22,],O
166237,22,to,O
166237,22,schedule,O
166237,22,an,O
166237,22,appointment,O
166237,22,for,O
166237,22,2,O
166237,22,weeks,O
166237,22,after,O
166237,22,discharge,O
166237,22,.,O
166237,22,.,O
166237,22,You,O
166237,22,will,O
166237,22,need,O
166237,22,to,O
166237,22,have,O
166237,22,your,O
166237,22,thyroid,O
166237,22,function,O
166237,22,tests,O
166237,22,checked,O
166237,22,in,O
166237,22,[,O
166237,22,**12-13**,O
166237,22,],O
166237,22,weeks,O
166237,22,.,O
166237,22,You,O
166237,22,should,O
166237,22,also,O
166237,22,have,O
166237,22,your,O
166237,22,blood,O
166237,22,counts,O
166237,22,and,O
166237,22,electrolytes,O
166237,22,checked,O
166237,22,on,O
166237,22,Friday,O
166237,22,",",O
166237,22,[,O
166237,22,**12-22**,O
166237,22,],O
166237,22,.,O
166237,22,[,O
166237,22,**First,O
166237,22,Name4,O
166237,22,(,O
166237,22,NamePattern1,O
166237,22,),O
166237,22,**,O
166237,22,],O
166237,22,[,O
166237,22,**Last,O
166237,22,Name,O
166237,22,(,O
166237,22,NamePattern1,O
166237,22,),O
166237,22,**,O
166237,22,],O
166237,22,MD,O
166237,22,[,O
166237,22,**MD,O
166237,22,Number,O
166237,22,(,O
166237,22,2,O
166237,22,),O
166237,22,4055**,O
166237,22,],O
